info icon

Dental operations

K11_DENTAL_OPER

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Primary healthcare outpatient: NOMESCO ^SAA02|^SAA03|^SAA04
  • Operations: NOMESCO codes ^SAA02|^SAA03|^SAA04

2 out of 7 registries used, show all original rules.

290470

4. Check minimum number of events

None

290470

5. Include endpoints

None

290470

6. Filter based on genotype QC (FinnGen only)

290470

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF7

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 290470 181728 108742
Unadjusted period prevalence (%) 56.70 61.94 47.94
Median age at first event (years) 50.70 47.89 55.41

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1516
Matched controls
12511
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K02.1
ICD-10 Finland
Caries of dentine
49.7
323.0
872
332
SAA01
NOMESCO Finland
Simple examination of mouth
27.7
323.0
992
799
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
40.9
323.0
573
183
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
42.2
323.0
512
149
SAA03
NOMESCO Finland
Extended examination of mouth
+∞
323.0
791
*
KMAK
NOMESCO Finland
NA
23.7
323.0
774
526
A98
ICPC
Health maint/preventive medicine
10.7
323.0
1131
2694
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
38.8
323.0
442
131
Z01.2
ICD-10 Finland
Dental examination
43.0
323.0
497
140
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
55.0
323.0
740
213
EB1AA
NOMESCO Finland
Tooth X-ray examination
36.4
323.0
762
338
SFA10
NOMESCO Finland
Fillning on one surface of tooth
53.8
323.0
836
279
EBA00
NOMESCO Finland
Extraction of tooth
24.8
323.0
651
368
WX110
NOMESCO Finland
Local anesthesy
16.7
323.0
989
1263
SAA02
NOMESCO Finland
Basic examination of mouth
+∞
323.0
1290
*
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
21.1
323.0
695
481
SDA02
NOMESCO Finland
Parodonthologic therapy
65.6
323.0
396
67
VALMI
NOMESCO Finland
NA
85.4
305.5
358
45
-1
NOMESCO Finland
NA
25.8
302.9
458
206
D82
ICPC
Teeth/gum disease
44.6
263.7
345
82
N02BE01
ATC
paracetamol; systemic, rectal
9.4
261.5
1324
5299
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
80.3
257.4
305
39
K04.5
ICD-10 Finland
Chronic apical periodontitis
25.8
235.4
354
146
SFA40
NOMESCO Finland
Replacement of krone of tooth
34.1
231.6
322
98
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
15.1
231.3
427
317
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
40.1
230.0
308
79
WZA90
NOMESCO Finland
Other doctors statement
43.6
229.6
302
71
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
30.1
229.0
329
114
WX290
NOMESCO Finland
Other blockade of nerve
20.5
218.4
354
183
SDA01
NOMESCO Finland
Simple parodonthologic therapy
48.3
213.5
275
57
WZB00
NOMESCO Finland
Telephone receipt or other advice
19.5
208.8
344
185
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
238.0
205.8
222
9
S18
ICPC
Laceration/cut
7.3
190.3
555
919
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
40.2
189.1
253
62
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
16.8
187.3
326
200
J01DB01
ATC
cefalexin; oral
5.2
182.6
1128
4471
EBA05
NOMESCO Finland
Complicated extraction of tooth
30.7
177.4
253
81
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
16.5
167.5
293
179
K03.64
ICD-10 Finland
Dental calculus supragingival
82.8
162.6
193
22
D19
ICPC
Teeth/gum symptom/complaint
27.6
159.6
234
82
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
55.4
158.1
199
34
SPAT1263
SPAT
Sampling
5.2
156.3
635
1527
SPAT1256
SPAT
Intramuscular and subcutaneous injection
5.7
150.5
539
1111
SPAT1325
SPAT
Vaccination
5.2
146.3
574
1308
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.5
139.5
684
1947
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
102.4
125.8
146
13
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
5.5
121.1
428
836
K05.30
ICD-10 Finland
Periodontitis complex
45.0
120.1
157
32
A28
ICPC
Limited function/disability NOS
4.5
119.8
545
1395
L28
ICPC
Limited function/disability (L)
5.0
118.8
470
1040
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
30.4
117.9
168
51
SPAT1301
SPAT
No procedures
4.5
117.5
528
1330
SPAT1216
SPAT
Assessment of functional ability
5.3
116.2
425
859
SPAT1053
SPAT
Memory test
5.2
115.9
427
870
SPAT1153
SPAT
Removal of sutures
6.3
114.5
351
570
SFA00
NOMESCO Finland
Small filling
50.3
112.5
144
26
K08.3
ICD-10 Finland
Retained dental root
20.4
111.1
178
81
SPAT1249
SPAT
Treatment-related counselling outside office
4.8
109.2
443
994
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
3.4
108.6
966
4242
Z02.4
ICD-10 Finland
Examination for driving licence
6.5
106.8
317
489
P20
ICPC
Memory disturbance
4.9
105.4
410
875
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
4.4
105.1
474
1177
AA1AD
NOMESCO Finland
CT of head and brain
4.2
103.8
498
1309
I10
ICD-10 Finland
Essential (primary) hypertension
3.3
103.0
1006
4651
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
5.2
102.9
378
755
SPAT1254
SPAT
Administration of medicine
4.5
100.4
428
998
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
4.5
100.3
431
1013
J01CA04
ATC
amoxicillin; systemic
3.2
97.8
991
4625
SPAT1222
SPAT
Counselling/guidance promoting independent living
4.6
97.2
409
938
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
4.7
96.6
396
883
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
33.0
94.7
132
36
EBA30
NOMESCO Finland
Excision of root of tooth
22.3
94.6
147
60
H13
ICPC
Plugged feeling ear
5.7
93.7
306
527
J01CE02
ATC
phenoxymethylpenicillin; oral
3.2
91.5
757
3005
K05.31
ICD-10 Finland
Periodontitis pronounced
18.9
89.1
146
70
A02BC02
ATC
pantoprazole; systemic
3.0
88.6
882
3945
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.5
85.9
535
1704
H81
ICPC
Excessive ear wax
5.1
85.3
313
612
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
5.6
83.5
274
470
N40
ICD-10 Finland
Hyperplasia of prostate
3.0
83.3
707
2801
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
3.4
82.8
518
1647
SPAT1310
SPAT
Counselling related to known health issue
4.9
82.0
309
620
M79.6
ICD-10 Finland
Pain in limb
4.2
81.5
370
895
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
4.8
80.3
306
620
N02AJ06
ATC
codeine and paracetamol; systemic
6.2
80.2
242
372
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
3.1
79.3
628
2352
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
29.5
79.0
113
34
L17
ICPC
Foot/toe symptom/complaint
5.8
78.2
249
409
SPAT1149
SPAT
Suture or treatment of traumatic wound
6.0
76.4
235
369
SPAT1148
SPAT
Treatment of chronic ulcer or burn
4.5
75.9
312
680
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.3
75.3
482
1536
SPAT1312
SPAT
General health counselling
4.7
74.2
288
591
K03.66
ICD-10 Finland
Tooth plaque
122.1
73.5
84
6
HMAK
NOMESCO Finland
NA
22.0
73.4
114
46
R23.8
ICD-10 Finland
Other and unspecified skin changes
7.2
72.2
192
246
H25.1
ICD-10 Finland
Senile nuclear cataract
2.7
71.4
805
3693
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
63.5
70.6
87
12
SAA04
NOMESCO Finland
Special inverstigation of mouth
+∞
70.2
72
*
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
13.9
70.2
129
83
M01AH05
ATC
etoricoxib; oral
3.4
70.2
413
1226
K02.2
ICD-10 Finland
Caries of cementum
37.5
69.5
94
22
S29
ICPC
Skin symptom/complaint other
6.8
69.0
192
262
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
32.4
68.7
96
26
B01AB05
ATC
enoxaparin; parenteral
3.6
66.6
369
1039
A29
ICPC
General symptom/complaint other
5.2
66.6
233
424
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
4.4
65.3
270
585
L57.0
ICD-10 Finland
Actinic keratosis
4.5
64.8
263
559
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
16.4
64.7
111
60
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.8
64.1
561
2167
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
5.0
64.0
231
434
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
4.1
63.6
288
679
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.6
63.3
682
2974
SGA01
NOMESCO Finland
Tooth opening as first aid
28.4
63.2
91
28
A04
ICPC
Weakness/tiredness general
4.0
62.8
292
705
SPAT1262
SPAT
Handing over of treatment supplies
4.2
62.7
273
620
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
52.8
62.4
79
13
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
60.6
62.2
77
11
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.1
62.1
280
657
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
24.0
61.6
93
34
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.9
60.9
498
1830
M54.5
ICD-10 Finland
Low back pain
3.8
60.8
303
776
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
20.9
59.1
93
39
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
8.2
58.7
142
156
SPAT1260
SPAT
Consultation of another employee
4.8
58.6
217
417
XKD00
NOMESCO Finland
Uroflowmetry
3.1
58.6
400
1299
E0000UV
ATC
NA
2.8
58.3
499
1878
EBA15
NOMESCO Finland
Extraction of large number of teeth
16.0
57.8
100
55
SPAT1097
SPAT
Recording of ECG
4.8
57.8
215
415
C10AA01
ATC
simvastatin; oral
2.4
57.4
777
3772
EBA10
NOMESCO Finland
Surgical removal of tooth
13.8
57.2
105
67
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
14.6
55.9
100
60
S02.51
ICD-10 Finland
Fracture of tooth, open
33.4
55.6
77
20
H02
ICPC
Hearing complaint
5.2
54.8
189
335
SPAT1229
SPAT
Assessment of need for aid
4.6
53.9
207
412
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.4
53.8
733
3528
K78
ICPC
Atrial fibrillation/flutter
4.4
53.0
218
464
C08CA01
ATC
amlodipine; oral
2.5
52.8
577
2467
SFC92
NOMESCO Finland
Other demanding adjuvant procedure of filling therapy
29.5
52.7
75
22
C07AB07
ATC
bisoprolol; oral
2.3
52.0
882
4698
L82
ICD-10 Finland
Seborrhoeic keratosis
5.3
52.0
175
301
SPF30
NOMESCO Finland
Soling for prothesis
26.3
51.8
76
25
R05
ICPC
Cough
5.2
51.7
178
314
G04CA02
ATC
tamsulosin; oral
2.3
51.4
707
3392
WX320
NOMESCO Finland
Spinalanesthesy
3.5
51.0
279
761
SGC00
NOMESCO Finland
Local medication of root channels of tooth
39.1
50.9
68
15
B01AF02
ATC
apixaban; oral
5.0
50.8
179
324
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
3.8
50.2
241
590
WX002
NOMESCO Finland
Sedation and analgesia
4.0
50.0
225
520
L15
ICPC
Knee symptom/complaint
6.3
49.8
145
208
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.9
49.3
370
1261
R42
ICD-10 Finland
Dizziness and giddiness
2.7
49.3
416
1525
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.7
49.3
244
613
K02.0
ICD-10 Finland
Caries limited to enamel
82.9
48.9
58
6
G04CA52
ATC
tamsulosin and dutasteride; systemic
4.1
48.7
213
479
ECB00
NOMESCO Finland
Suture of gingiva
26.7
48.6
71
23
K04.1
ICD-10 Finland
Necrosis of pulp
22.9
48.5
74
28
C10AA05
ATC
atorvastatin; oral
2.6
48.2
452
1758
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
4.1
47.6
210
476
SPAT1043
SPAT
Audiometry
5.3
47.3
157
265
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
2.5
47.0
462
1841
M01AX05
ATC
glucosamine; oral
3.0
46.4
325
1053
SPAT1211
SPAT
Application of soft bandage
5.4
46.3
151
249
ZXA05
NOMESCO Finland
Left side
2.6
46.1
444
1744
L03
ICPC
Low back symptom/complaint
5.1
45.3
157
278
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.2
44.3
717
3628
R53
ICD-10 Finland
Malaise and fatigue
2.5
44.3
454
1837
A97
ICPC
No disease
4.7
43.7
163
312
ZXA00
NOMESCO Finland
Right side
2.5
43.4
451
1835
K02
ICD-10 Finland
Dental caries
22.7
43.3
66
25
B01AF01
ATC
rivaroxaban; oral
6.3
43.2
124
174
H29
ICPC
Ear symptom/complaint other
6.2
43.1
125
178
T90
ICPC
Diabetes non-insulin dependent
3.4
42.9
236
641
M17.1
ICD-10 Finland
Other primary gonarthrosis
3.2
42.9
258
748
R07.4
ICD-10 Finland
Chest pain, unspecified
2.7
42.8
363
1318
N06AX11
ATC
mirtazapine; oral
2.5
42.5
411
1604
L13
ICPC
Hip symptom/complaint
4.9
42.4
151
275
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
3.6
42.3
218
562
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.8
41.7
311
1042
N17
ICPC
Vertigo/dizziness
4.8
41.6
153
288
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.6
41.2
213
550
215
Kela drug reimbursment
Diabetes, non-insulin-treated
3.7
41.1
200
491
L08
ICPC
Shoulder symptom/complaint
5.3
40.1
132
220
Z01.1
ICD-10 Finland
Examination of ears and hearing
3.3
40.0
228
632
S21
ICPC
Skin texture symptom/complaint
5.8
39.9
123
189
G04BD12
ATC
mirabegron; oral
5.8
39.9
123
189
SPAT1304
SPAT
Counselling and guidance related to ageing
4.2
39.9
167
358
UKC02
NOMESCO Finland
Cystoscopy
2.5
39.8
401
1593
SCA03
NOMESCO Finland
Preventive oral health care, extensive
35.4
39.7
54
13
M25.5
ICD-10 Finland
Pain in joint
4.1
39.3
170
376
SPAT1252
SPAT
Overall medication plan or its review
4.1
39.0
170
378
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
17.7
38.8
64
31
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
5.0
38.4
135
242
NF1AA
NOMESCO Finland
Hip X-ray examination
3.9
38.3
175
406
WX100
NOMESCO Finland
Conjunctival surface anesthesia
4.1
38.0
163
357
R4110
NOMESCO Finland
Physiotherapy
2.7
37.7
301
1045
DFF00
NOMESCO Finland
Pure tone audiometry
6.1
37.6
110
158
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
13.9
37.6
68
42
Z97.2
ICD-10 Finland
Presence of dental prosthetic device (complete)(partial)
20.2
37.4
59
25
K85
ICPC
Elevated blood pressure
3.9
37.4
168
384
SGC10
NOMESCO Finland
Covering pulpa of tooth
27.1
37.3
54
17
N06DX01
ATC
memantine; oral
2.7
37.3
307
1086
N02AA05
ATC
oxycodone; systemic
2.5
36.8
338
1272
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
3.4
36.5
202
548
Z71.8
ICD-10 Finland
Other specified counselling
3.8
36.4
172
410
R05
ICD-10 Finland
Cough
3.7
36.3
178
438
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
3.5
36.3
186
475
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
6.1
36.1
106
153
J01MA02
ATC
ciprofloxacin; systemic
2.1
35.9
642
3296
R02
ICPC
Shortness of breath/dyspnoea
4.1
35.8
154
338
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
35.6
259
846
R31
ICD-10 Finland
Unspecified haematuria
2.7
35.5
290
1016
C09AA05
ATC
ramipril; oral
2.2
35.4
496
2290
Z51.5
ICD-10 Finland
Palliative care
4.5
35.3
137
272
Z00.0
ICD-10 Finland
General medical examination
3.0
35.3
234
719
U02
ICPC
Urinary frequency/urgency
5.5
34.9
111
177
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
3.9
34.9
158
363
K05.3
ICD-10 Finland
Chronic periodontitis
25.6
34.7
51
17
L01
ICPC
Neck symptom/complaint
7.9
34.7
84
92
H26.4
ICD-10 Finland
After-cataract
2.8
34.6
255
841
R60.0
ICD-10 Finland
Localized oedema
3.4
34.4
185
490
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.8
34.3
158
368
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.5
34.2
178
459
G04CB02
ATC
dutasteride; oral
3.4
34.2
187
501
M01AE01
ATC
ibuprofen; systemic, rectal
2.0
34.0
817
4673
SPAT1305
SPAT
Counselling and guidance related to physical exercise
4.1
33.9
143
308
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
5.2
33.7
112
188
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
21.1
33.5
52
21
N30.0
ICD-10 Finland
Acute cystitis
2.9
33.1
229
722
K05.1
ICD-10 Finland
Chronic gingivitis
82.5
33.0
39
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
32.9
221
683
G04CA01
ATC
alfuzosin; oral
2.6
32.8
273
964
SPAT1234
SPAT
Support of social functional capacity
3.8
32.3
148
343
-44
ICPC
Preventive immunization/medic
4.5
32.0
121
234
L12
ICPC
Hand/finger symptom/complaint
5.5
32.0
101
160
R01AD09
ATC
mometasone; nasal
2.5
31.8
290
1077
ZXA10
NOMESCO Finland
Bilateral
2.6
31.8
272
974
CJB10
NOMESCO Finland
Laser discission of secondary cataract
2.9
31.4
210
647
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
33.1
31.3
43
11
SPAT1360
SPAT
Extensive global examination
4.1
31.2
131
280
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.5
31.2
160
407
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.6
31.2
268
961
A03
ICPC
Fever
4.8
30.7
110
201
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.3
30.6
333
1353
N03AX16
ATC
pregabalin; oral
2.7
30.5
238
807
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
32.4
30.4
42
11
DAX08
NOMESCO Finland
Fitting of hearing aid
5.4
30.4
98
159
D01BA02
ATC
terbinafine; oral; topical
2.6
30.2
244
845
UJF32
NOMESCO Finland
Coloscopy
2.3
30.1
318
1271
SPAT1100
SPAT
Long-term monitoring of blood pressure
3.3
29.8
167
455
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
9.3
29.7
65
60
X59
ICD-10 Finland
Exposure to unspecified factor
3.0
29.6
187
552
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
4.7
29.5
107
198
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
4.9
29.2
102
181
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.6
29.2
142
346
S82
ICPC
Naevus/mole
5.8
29.1
87
129
D07AC01
ATC
betamethasone; topical
2.1
28.9
399
1802
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.2
28.8
170
479
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
28.7
271
1020
K05.18
ICD-10 Finland
Chronic gingivitis
262.9
28.6
31
*
M16.1
ICD-10 Finland
Other primary coxarthrosis
3.0
28.6
186
561
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
11.7
28.4
55
40
M75.1
ICD-10 Finland
Rotator cuff syndrome
3.4
28.3
151
396
SXC05
NOMESCO Finland
Other oral or dental procedure
35.7
28.2
38
9
C03CA01
ATC
furosemide; systemic
1.8
28.1
937
5840
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.1
28.0
168
480
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.1
27.8
170
491
A11
ICPC
Chest pain NOS
5.7
27.6
84
127
SGA04
NOMESCO Finland
Very demanding opening and dilatation of root canal of tooth
26.0
27.5
40
13
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
26.0
27.5
40
13
S15
ICPC
Foreign body in skin
8.7
27.4
62
61
U04
ICPC
Incontinence urine
4.6
27.3
101
191
K04.7
ICD-10 Finland
Periapical abscess without sinus
10.4
27.3
56
46
SPAT1101
SPAT
Orthostatic test
3.9
27.2
121
273
K86
ICPC
Hypertension uncomplicated
3.8
27.1
123
282
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
4.9
27.1
94
166
K08.80
ICD-10 Finland
Toothache NOS
24.2
27.0
40
14
DFF15
NOMESCO Finland
Speech audiometry
6.1
26.9
78
111
B01AC04
ATC
clopidogrel; oral
2.3
26.9
303
1241
M03BX02
ATC
tizanidine; oral
2.1
26.9
355
1564
M70.6
ICD-10 Finland
Trochanteric bursitis
5.5
26.8
84
132
A01
ICPC
Pain general/multiple sites
4.4
26.7
103
203
R01AD12
ATC
fluticasone furoate; nasal
4.3
26.7
107
219
SFC00
NOMESCO Finland
Pillar of fillings material
47.8
26.7
34
6
A06AC01
ATC
ispaghula (psylla seeds); oral
2.1
26.3
351
1551
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.2
26.3
106
218
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.1
26.3
356
1582
ZXC50
NOMESCO Finland
Cryotherapy
6.6
26.3
71
92
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
2.8
26.1
190
614
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
3.4
25.9
138
361
H25.8
ICD-10 Finland
Other senile cataract
2.3
25.8
286
1162
Y77
ICPC
Malignant neoplasm prostate
5.6
25.3
78
120
H91.1
ICD-10 Finland
Presbycusis
2.6
25.2
206
713
A44
ICPC
General and Unspecified, Preventive immunization/medic
5.1
25.2
84
142
-31
ICPC
Medical examin/health eval partial
4.0
25.1
106
228
S02.53
ICD-10 Finland
Fracture of tooth root
39.7
25.1
33
7
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
5.4
25.1
79
125
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.6
25.0
199
677
S06.0
ICD-10 Finland
Concussion
2.9
25.0
171
532
SPF40
NOMESCO Finland
Removal and reattachment with cement of tooth crone or short bridge
29.5
24.9
35
10
Z01.8
ICD-10 Finland
Other specified special examinations
2.6
24.9
207
722
M01AB05
ATC
diclofenac; systemic, rectal
1.8
24.9
605
3339
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
3.2
24.9
144
400
K59.09
ICD-10 Finland
Constipation, unspecified
3.7
24.9
117
277
K04.62
ICD-10 Finland
Periradicular abscess with fistula to mouth
227.3
24.8
27
*
S04
ICPC
Lump/swelling localized
5.9
24.6
72
104
WZA00
NOMESCO Finland
Short statement of of health and health related matters
15.5
24.5
42
23
Z97.4
ICD-10 Finland
Presence of external hearing-aid
2.9
24.4
161
489
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
3.3
24.4
131
345
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
3.6
24.3
117
282
U07
ICPC
Urine symptom/complaint other
5.0
24.2
82
141
R21
ICPC
Throat symptom/complaint
6.2
24.0
68
94
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
24.0
379
1787
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
4.7
23.8
85
155
K04.0
ICD-10 Finland
Pulpitis
17.3
23.8
39
19
P70
ICPC
Dementia
3.8
23.7
109
253
TUPEI
NOMESCO Finland
NA
61.0
23.7
29
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
113.3
23.7
27
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
5.3
23.5
76
124
L14
ICPC
Leg/thigh symptom/complaint
5.2
23.5
77
128
J20
ICD-10 Finland
Acute bronchitis
4.3
23.4
91
181
K07
ICPC
Swollen ankles/oedema
4.6
23.4
85
158
A99
ICPC
Disease/condition unspecnature/site
3.9
23.3
103
231
EMAK
NOMESCO Finland
NA
37.2
23.3
31
7
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.8
23.3
164
518
-60
ICPC
Result test/procedure
4.4
23.3
90
178
M05BX04
ATC
denosumab; parenteral
6.2
23.2
65
89
R06.0
ICD-10 Finland
Dyspnoea
2.0
23.1
355
1653
D01AE16
ATC
amorolfine; topical
2.9
22.7
153
470
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
6.9
22.6
59
73
Z01.7
ICD-10 Finland
Laboratory examination
3.9
22.6
98
216
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.0
22.6
97
212
SPAT1281
SPAT
Other administrative function
4.5
22.4
84
161
SPAT1167
SPAT
Insertion of urinary catheter
3.7
22.4
103
239
SPAT1104
SPAT
Monitoring of emergency patient
3.7
22.4
103
239
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
3.4
22.3
117
302
F51.0
ICD-10 Finland
Nonorganic insomnia
4.4
22.3
85
166
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
7.4
22.2
55
63
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
4.0
22.2
94
203
I50.9
ICD-10 Finland
Heart failure, unspecified
1.8
22.0
562
3119
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.0
22.0
317
1433
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.6
22.0
173
585
S97
ICPC
Chronic ulcer skin
3.8
21.8
97
219
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.3
21.8
120
320
G04BD08
ATC
solifenacin; oral
3.3
21.7
116
304
M01AC06
ATC
meloxicam; systemic, rectal
2.0
21.5
340
1595
SCF01
NOMESCO Finland
Preventive oral care by dental hygienist or dental assistant, restricted
12.5
21.5
40
27
AN1
HP
Coronary angiography
2.3
21.5
225
883
A02BC05
ATC
esomeprazole; systemic
1.9
21.4
399
1988
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.3
21.3
113
295
WZC30
NOMESCO Finland
Teaching
6.0
21.1
61
87
SPAT1212
SPAT
Extensive examination of musculoskeletal system
6.2
21.0
59
81
M54.4
ICD-10 Finland
Lumbago with sciatica
4.1
21.0
86
180
A46
ICD-10 Finland
Erysipelas
2.3
21.0
227
906
L05
ICPC
Flank/axilla symptom/complaint
6.5
21.0
57
75
SDA05
NOMESCO Finland
Very demanding and lengthy parodonthologic therapy
192.5
21.0
23
*
D11
ICPC
Diarrhoea
4.7
20.9
75
138
R52.9
ICD-10 Finland
Pain, unspecified
4.5
20.8
78
150
J01AA02
ATC
doxycycline; systemic
1.7
20.7
947
6201
L16
ICPC
Ankle symptom/complaint
5.3
20.5
65
104
SPAT1172
SPAT
Guidance concerning hydration
4.1
20.5
84
176
SBB10
NOMESCO Finland
Teeth copy
21.7
20.4
31
12
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.6
20.4
161
544
M54
ICD-10 Finland
Dorsalgia
4.0
20.4
85
181
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.4
20.3
106
273
S12
ICPC
Insect bite/sting
7.2
20.3
51
60
S19
ICPC
Skin injury other
5.4
20.3
64
102
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.6
20.2
160
542
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
20.1
273
1201
I25
ICD-10 Finland
Chronic ischaemic heart disease
3.2
20.0
113
308
SPE01
NOMESCO Finland
Mucosa-supported partial denture
184.0
20.0
22
*
EB1AA
SPAT
NA
67.1
19.9
24
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
3.8
19.8
89
203
K04.08
ICD-10 Finland
Other specified pulpit
24.4
19.8
29
10
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
24.4
19.8
29
10
TQW99
NOMESCO Finland
Other minor procedure on skin
3.6
19.8
95
229
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
19.8
208
818
U05
ICPC
Urination problems other
4.2
19.8
79
162
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
2.8
19.6
136
424
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.5
19.5
169
602
SCF02
NOMESCO Finland
Preventive oral care by dental hygienist
13.4
19.5
35
22
A10BH01
ATC
sitagliptin; oral
3.1
19.5
115
324
Z02.7
ICD-10 Finland
Issue of medical certificate
3.6
19.4
94
228
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
4.7
19.4
69
126
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
3.0
19.3
118
339
SPC35
NOMESCO Finland
Production and attachment of single tooth bridge
41.9
19.3
25
5
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.1
19.3
263
1157
L02
ICPC
Back symptom/complaint
5.8
19.3
57
84
SPAT1255
SPAT
Intravenous administration of medicine
3.6
19.2
93
226
C61
ICD-10 Finland
Malignant neoplasm of prostate
2.0
19.1
278
1254
N05AH04
ATC
quetiapine; oral
2.3
19.0
204
807
WX110
SPAT
NA
92.0
19.0
22
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
18.9
255
1118
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
3.3
18.9
101
265
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
2.1
18.9
237
1007
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
2.9
18.8
122
366
SPAT1139
SPAT
Nutrition survey
4.3
18.8
73
146
R55
ICD-10 Finland
Syncope and collapse
2.1
18.7
232
979
N03AX12
ATC
gabapentin; oral
2.9
18.6
119
354
R07.3
ICD-10 Finland
Other chest pain
2.9
18.6
119
354
207
Kela drug reimbursment
Chronic arrhythmias
2.0
18.5
270
1222
S16
ICPC
Bruise/contusion
6.3
18.5
51
69
J05AB01
ATC
aciclovir; systemic
2.2
18.4
205
826
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
2.4
18.4
168
615
KED22
NOMESCO Finland
Transurethral resection of prostate
2.2
18.4
215
884
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.9
18.4
121
365
R74
ICPC
Upper respiratory infection acute
3.9
18.3
80
178
R35
ICD-10 Finland
Polyuria
3.3
18.3
96
249
-50
ICPC
Medication/prescr/renewal
3.9
18.2
78
171
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
18.1
710
4384
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
3.5
18.1
88
215
L29
ICPC
Musculoskeletal sympt/complt other
4.3
18.0
70
140
Z46.3
ICD-10 Finland
Fitting and adjustment of dental prosthetic device
19.6
18.0
28
12
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
18.0
355
1790
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
4.1
17.9
72
149
B01AA03
ATC
warfarin; systemic
1.6
17.9
616
3670
M79.1
ICD-10 Finland
Myalgia
4.5
17.8
65
122
R83
ICPC
Respiratory infection other
4.8
17.8
62
111
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
3.1
17.7
104
290
TPH07
NOMESCO Finland
Cathetrisation of artery
2.8
17.7
121
373
L03.0
ICD-10 Finland
Cellulitis of finger and toe
4.5
17.7
65
123
SAB02
NOMESCO Finland
Oral and dental health check by dental hygienist or dental assistant
7.7
17.6
42
46
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.6
17.6
134
442
Z76.0
ICD-10 Finland
Issue of repeat prescription
3.4
17.6
90
229
R33
ICD-10 Finland
Retention of urine
2.0
17.5
252
1129
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
13.7
17.5
31
19
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
7.3
17.3
43
50
S01.0
ICD-10 Finland
Open wound of scalp
2.5
17.3
147
517
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
3.3
17.2
93
246
C09CA06
ATC
candesartan; oral
2.2
17.2
188
749
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
4.0
17.0
70
148
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
6.1
17.0
48
67
ZZR00
NOMESCO Finland
Flap of skin
4.1
17.0
68
140
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.7
16.9
50
74
H60.9
ICD-10 Finland
Otitis externa, unspecified
6.6
16.9
45
58
Z01.9
ICD-10 Finland
Special examination, unspecified
5.2
16.9
54
88
M48.0
ICD-10 Finland
Spinal stenosis
2.3
16.9
165
622
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
4.6
16.9
60
110
D06BB10
ATC
imiquimod; topical
4.5
16.8
62
118
XJH00
NOMESCO Finland
Transanal ultrasonography
2.2
16.7
176
690
R81
ICPC
Pneumonia
4.7
16.7
58
104
SGB30
NOMESCO Finland
Other demanding filling of root channel of tooth
25.1
16.6
24
8
M03BC01
ATC
orphenadrine (citrate); systemic
3.1
16.5
96
268
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
16.5
289
1395
K29
ICPC
Cardiovascular sympt/complt other
4.1
16.4
67
141
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.5
16.3
81
201
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
1.9
16.3
261
1217
C10AA07
ATC
rosuvastatin; oral
2.7
16.3
120
387
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.5
16.3
159
2346
R06AE07
ATC
cetirizine; oral
1.8
16.3
327
1649
L04
ICPC
Chest symptom/complaint
6.8
16.3
42
52
B81
ICPC
Anaemia vit B12/folate deficiency
3.6
16.2
75
176
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.6
16.2
75
176
H61.2
ICD-10 Finland
Impacted cerumen
3.6
16.2
75
176
R96
ICPC
Asthma
4.9
16.2
55
96
A27
ICPC
Fear of other disease NOS
5.5
16.2
49
75
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.1
16.2
93
258
L11
ICPC
Wrist symptom/complaint
5.4
16.1
50
79
R03AC02
ATC
salbutamol; inhalant
1.6
16.0
498
2862
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
4.4
16.0
60
116
-54
ICPC
Repair/fix-suture/cast/prosth device
6.2
15.9
44
60
D02AE01
ATC
carbamide; topical
3.7
15.9
71
162
J45
ICD-10 Finland
Asthma
3.7
15.9
71
162
SPAT1231
SPAT
Assessment of adjustments needed in living environment
4.4
15.8
59
114
R06AX27
ATC
desloratadine; oral
2.8
15.8
110
344
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.5
15.8
77
189
R51.80
ICD-10 Finland
Headache
3.0
15.7
94
267
G30.1
ICD-10 Finland
Alzheimer disease with late onset
1.9
15.7
263
1246
K91
ICPC
Cerebrovascular disease
8.9
15.7
34
32
SXA20
NOMESCO Finland
Local application of medicine to mouth
20.1
15.6
24
10
SPAT1251
SPAT
Organisation of medication
2.6
15.6
119
393
C09CA01
ATC
losartan; oral
1.9
15.6
255
1198
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
2.1
15.5
185
767
116
Kela drug reimbursment
Prostate cancer
2.1
15.4
201
865
H84
ICPC
Presbyacusis
3.6
15.4
73
175
JN4AD
NOMESCO Finland
Body CT examination
4.2
15.4
61
125
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
5.4
15.4
47
73
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
52.8
15.4
19
*
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
4.5
15.3
56
106
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
141.7
15.2
17
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
4.6
15.2
54
99
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
0.1
15.2
*
391
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
5.1
15.2
49
81
K05.38
ICD-10 Finland
Other chronic periodontitis
12.4
15.2
28
19
SPAT1081
SPAT
Cardiorespiratory global assessment
3.4
15.2
77
195
L76
ICPC
Fracture: other
4.8
15.2
52
92
L90
ICPC
Osteoarthrosis of knee
6.0
15.1
43
61
K02.8
ICD-10 Finland
Other dental caries
16.1
15.1
25
13
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
5.1
15.0
49
82
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
3.6
15.0
71
170
U28
ICPC
Limited function/disability (U)
6.7
15.0
39
49
P01AB01
ATC
metronidazole; oral, rectal
1.7
14.9
341
1786
SCF03
NOMESCO Finland
Preventive oral care by dental hygienist, extensive
33.4
14.9
20
5
C08CA13
ATC
lercanidipine; oral
2.2
14.9
155
605
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.6
14.8
112
369
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
6.4
14.8
40
53
-69
ICPC
Other reason for encounter NEC
3.9
14.7
62
135
M10
ICD-10 Finland
Gout
3.7
14.6
65
148
D07AC13
ATC
mometasone; topical
1.8
14.6
302
1533
L02AE02
ATC
leuprorelin; implant, parenteral
2.3
14.5
138
514
R00.1
ICD-10 Finland
Bradycardia, unspecified
2.8
14.5
99
305
I50
ICD-10 Finland
Heart failure
2.5
14.5
116
394
M02AA07
ATC
piroxicam; topical
1.6
14.5
494
2892
H02AB06
ATC
prednisolone; systemic
1.6
14.5
580
3538
N06DA02
ATC
donepezil; oral
2.0
14.5
207
923
K03.1
ICD-10 Finland
Abrasion of teeth
70.9
14.3
17
*
K03.00
ICD-10 Finland
Approximal wear
70.9
14.3
17
*
I49.5
ICD-10 Finland
Sick sinus syndrome
2.6
14.3
112
377
K05
ICPC
Irregular heartbeat other
5.2
14.2
45
73
K28
ICPC
Limited function/disability (K)
4.5
14.2
51
95
JN4BD
NOMESCO Finland
Extensive body CT
2.7
14.2
101
320
X58
ICD-10 Finland
Exposure to other specified factors
2.7
14.1
101
322
SAD02
NOMESCO Finland
Assessment of need for oral health care, extensive
8.7
14.1
31
30
S22.3
ICD-10 Finland
Fracture of rib
2.7
14.1
100
316
M16
ICD-10 Finland
Coxarthrosis [arthrosis of hip]
4.5
14.1
51
96
H04
ICPC
Ear discharge
5.1
14.1
45
74
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
3.7
14.0
64
149
Z50.1
ICD-10 Finland
Other physical therapy
3.5
14.0
67
162
SGB20
NOMESCO Finland
Filling of root of tooth with 2 root channels
31.7
14.0
19
5
S54
ICPC
Skin, Repair/fix-suture/cast/prosth device
7.7
14.0
33
36
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
18.4
14.0
22
10
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
13.1
14.0
25
16
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.5
13.9
51
97
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
0.5
13.9
92
1544
SPAT1285
SPAT
Provision of consultation response
3.9
13.9
58
125
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
13.9
240
1146
P06
ICPC
Sleep disturbance
4.7
13.9
48
86
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.9
13.8
213
974
S01EE05
ATC
tafluprost; ophthalmic
5.2
13.8
44
72
XCK10
NOMESCO Finland
Photography of fundus of eye
2.3
13.8
136
516
R5140
NOMESCO Finland
Monitoring the use of the aid
2.8
13.8
91
276
F16
ICPC
Eyelid symptom/complaint
6.6
13.7
36
46
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
3.1
13.7
78
215
U71
ICPC
Cystitis/urinary infection other
4.4
13.7
51
99
E000001
ATC
NA
1.8
13.7
248
1204
S01EE01
ATC
latanoprost; ophthalmic
2.2
13.7
146
573
N01
ICPC
Headache
5.9
13.7
39
56
S22
ICPC
Nail symptom/complaint
4.7
13.7
47
84
K77
ICPC
Heart failure
3.4
13.6
69
175
S01
ICPC
Pain/tenderness of skin
6.0
13.6
38
53
K05.39
ICD-10 Finland
Periodontitis UNS
16.7
13.5
22
11
S02.59
ICD-10 Finland
Tooth fracture UNS
47.2
13.5
17
*
D12
ICPC
Constipation
4.2
13.5
53
108
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
3.1
13.5
77
213
J01.0
ICD-10 Finland
Acute maxillary sinusitis
3.0
13.5
81
231
JN3AD
NOMESCO Finland
Abdominal CT examination
3.2
13.5
73
195
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
13.4
256
1263
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
3.9
13.4
57
125
S02.54
ICD-10 Finland
Fracture of both the crown and the root
26.4
13.4
19
6
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
4.6
13.4
47
86
R12
ICD-10 Finland
Heartburn
5.0
13.4
44
75
K03.08
ICD-10 Finland
Other wear and tear of the teeth
124.9
13.4
15
*
SCC01
NOMESCO Finland
Simple fluorination of mouth or other corresponding procedure
124.9
13.4
15
*
EBA00
SPAT
NA
124.9
13.4
15
*
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.5
13.3
564
3467
SPAT1058
SPAT
PEF monitoring instruction
5.8
13.2
38
55
M54.2
ICD-10 Finland
Cervicalgia
5.4
13.2
40
62
U06
ICPC
Haematuria
5.1
13.2
42
69
-62
ICPC
Administrative procedure
5.1
13.2
42
69
D06BX02
ATC
ingenol mebutate; topical
8.1
13.2
30
31
M01AH01
ATC
celecoxib; oral (coxibs)
1.9
13.1
197
893
D07AB02
ATC
hydrocortisone butyrate; topical
1.7
13.1
300
1567
H91.9
ICD-10 Finland
Hearing loss, unspecified
3.4
13.1
66
167
A08
ICPC
Swelling
4.1
13.0
52
108
SPAT1352
SPAT
Inspection, maintenance and instruction for use of hearing aid
3.7
13.0
57
129
WYA20
NOMESCO Finland
Home visit
3.2
13.0
69
182
B02.9
ICD-10 Finland
Zoster without complication
3.1
13.0
74
205
C05AA08
ATC
fluocortolone; rectal, topical
2.1
12.9
148
602
SPAT1014
SPAT
Treatment of eyes
4.1
12.9
51
105
R13
ICD-10 Finland
Dysphagia
2.9
12.9
83
249
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
35.4
12.9
17
*
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
2.8
12.8
84
255
D01
ICPC
Abdominal pain/cramps general
4.1
12.8
50
102
SPF20
NOMESCO Finland
Temporary soling for filling
15.9
12.7
21
11
B80
ICPC
Iron deficiency anaemia
7.6
12.7
30
33
S01ED51
ATC
timolol, combinations; ophthalmic
2.0
12.7
165
708
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
4.0
12.7
51
107
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
2.5
12.6
101
343
R01AD08
ATC
fluticasone; nasal
1.9
12.6
187
843
WX402
NOMESCO Finland
General anaesthesia
4.1
12.5
49
100
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
4.7
12.5
43
77
S79
ICPC
Neoplasm skin benign/unspecified
7.0
12.5
31
37
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.5
12.5
103
356
K03.6
ICD-10 Finland
Deposits [accretions] on teeth
116.5
12.4
14
*
SPA02
NOMESCO Finland
Preparation for dental prosthetics
116.5
12.4
14
*
H03AA01
ATC
levothyroxine sodium; systemic
1.9
12.4
209
989
SPAT1016
SPAT
Examination of vision
4.7
12.4
43
78
R5120
NOMESCO Finland
Preparation of an aid
3.3
12.4
63
161
SBA00
NOMESCO Finland
Microbiological examinations
14.6
12.4
21
12
M10.9
ICD-10 Finland
Gout, unspecified
2.4
12.3
113
412
S02
ICPC
Pruritus
6.3
12.3
33
44
N05AX08
ATC
risperidone; systemic
1.8
12.3
220
1062
H01
ICPC
Ear pain/earache
4.6
12.2
43
79
K25
ICPC
Fear of hypertension
5.4
12.1
37
58
R50.9
ICD-10 Finland
Fever, unspecified
1.9
12.1
198
925
UJF30
NOMESCO Finland
Ileoscopy through colon
3.7
12.1
54
124
H04.10
ICD-10 Finland
Dry eye syndrome
3.4
12.1
59
146
L86
ICPC
Back syndrome with radiating pain
6.7
12.1
31
39
K90
ICPC
Stroke/cerebrovascular accident
3.4
12.0
60
151
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.2
12.0
46
92
Z29
ICPC
Social problem NOS
4.7
12.0
41
73
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
4.6
12.0
42
77
XF404
NOMESCO Finland
Ambulatory ECG
2.5
12.0
95
323
W19
ICD-10 Finland
Unspecified fall
2.1
11.9
149
627
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
4.1
11.9
47
97
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
5.4
11.9
36
56
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.7
11.9
82
258
SPAT1282
SPAT
Assessment of ability to drive and opinion
5.6
11.8
35
53
DAB00
NOMESCO Finland
Excision of lesion of auricle
5.2
11.8
37
60
J05AB11
ATC
valaciclovir; oral
2.5
11.8
97
336
B01AE07
ATC
dabigatran etexilate; oral
4.3
11.8
44
86
NA1AD
NOMESCO Finland
Cervical spine CT examination
4.1
11.8
46
94
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.5
11.8
603
3836
XQ848
NOMESCO Finland
Dermatological photography
5.7
11.8
34
50
I49.3
ICD-10 Finland
Ventricular premature depolarization
3.5
11.8
56
136
SDC10
NOMESCO Finland
Parodontological fixation
23.6
11.7
17
6
ND1AA
NOMESCO Finland
Wrist X-ray examination
4.5
11.7
42
79
TKC20
NOMESCO Finland
Catheterisation of bladder
2.0
11.7
165
729
-59
ICPC
Other therap proced/minor surg NEC
6.1
11.7
32
44
R03DA04
ATC
theophylline; systemic, rectal
0.5
11.7
88
1417
S61.9
ICD-10 Finland
Open wound of wrist and hand, part unspecified
6.6
11.6
30
38
L09
ICPC
Arm symptom/complaint
6.6
11.6
30
38
WX199
NOMESCO Finland
Other local analgesia
6.6
11.6
30
38
A06AC51
ATC
ispaghula, combinations; systemic
3.5
11.6
54
129
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.3
11.6
58
147
I95.1
ICD-10 Finland
Orthostatic hypotension
2.4
11.6
103
371
M01AE02
ATC
naproxen; oral, rectal
1.5
11.5
463
2786
XX3DW
NOMESCO Finland
Time consuming IT work
3.6
11.5
52
121
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
3.3
11.5
59
152
D20
ICPC
Mouth/tongue/lip symptom/complaint
8.1
11.5
26
27
L84
ICPC
Back syndrome without radiat pain
6.2
11.5
31
42
M15
ICD-10 Finland
Polyarthrosis
3.9
11.4
48
105
F21
ICPC
NA
5.5
11.4
34
52
NK6AN
NOMESCO Finland
Total body bone isotope imaging
5.5
11.4
34
52
F29
ICPC
Eye symptom/complaint other
3.8
11.3
49
110
U29
ICPC
Urinary symptom/complaint other
4.8
11.3
38
67
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
4.8
11.3
38
67
UDC00
NOMESCO Finland
Ear microscopy
3.2
11.3
60
159
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
0.3
11.3
31
737
M13.9
ICD-10 Finland
Arthritis, unspecified
3.2
11.2
60
160
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.9
11.2
174
796
J01FA10
ATC
azithromycin; systemic
1.6
11.1
328
1828
U08
ICPC
Urinary retention
4.6
11.1
39
72
WX892
NOMESCO Finland
Monitored bed care
2.6
11.1
86
288
WX140
NOMESCO Finland
Parabulbar anesthesy
3.3
11.1
56
143
SPAT1059
SPAT
Spirometry at the office
4.8
11.1
37
65
U01
ICPC
Dysuria/painful urination
4.8
11.1
37
65
RD211
NOMESCO Finland
NA
6.4
11.0
29
38
S06
ICPC
Rash localized
3.7
11.0
48
109
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.6
11.0
80
260
U13
ICPC
Bladder symptom/complaint other
4.4
11.0
40
77
J01FF01
ATC
clindamycin; systemic
1.7
10.9
237
1213
SPA40
NOMESCO Finland
Precision impression for dental prosthesis
22.2
10.9
16
6
D18
ICPC
Change in faeces/bowel movements
11.9
10.9
20
14
SPAT1050
SPAT
Extensive neurological examination
5.0
10.9
35
59
N05BA04
ATC
oxazepam; oral
1.6
10.9
347
1973
N06AX21
ATC
duloxetine; oral
3.1
10.9
61
167
K03.0
ICD-10 Finland
Excessive attrition of teeth
38.8
10.9
14
*
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.5
10.8
85
288
R03BB01
ATC
ipratropium bromide; inhalant
0.4
10.8
60
1075
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.0
10.8
62
174
J01FA09
ATC
clarithromycin; systemic
1.8
10.8
190
911
A60
ICPC
General and Unspecified, Result test/procedure
4.3
10.7
40
79
114
Kela drug reimbursment
Glaucoma
1.8
10.7
211
1049
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
10.7
66
194
SGA05
NOMESCO Finland
Very demanding and lengthy opening and dilatation of root canal of tooth
54.0
10.6
13
*
S52.5
ICD-10 Finland
Fracture of lower end of radius
2.5
10.6
86
295
D06
ICPC
Abdominal pain localized other
4.4
10.6
38
72
H11.3
ICD-10 Finland
Conjunctival haemorrhage
4.2
10.6
40
80
K03.88
ICD-10 Finland
Other specified diseases of hard tissues of teeth
25.0
10.6
15
5
EKA10
NOMESCO Finland
Biopsy of cheek
11.1
10.6
20
15
SPA47
NOMESCO Finland
Precision impression for denture
99.7
10.5
12
*
NFB40
NOMESCO Finland
Primary total prosthetic replacement of hip joint using hybrid technique
4.7
10.5
36
65
A23
ICPC
Risk factor NOS
3.7
10.5
46
105
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
2.3
10.5
96
350
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
5.7
10.5
30
44
Y06
ICPC
Prostate symptom/complaint
4.2
10.4
40
81
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
3.6
10.4
47
110
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.8
10.4
68
206
K04
ICPC
Palpitations/awareness of heart
6.8
10.4
26
32
SPAT1157
SPAT
Guidance concerning treatment of mouth and mucous membranes
5.2
10.3
32
52
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
2.3
10.3
95
350
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.0
10.3
143
630
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.2
10.3
9
394
SPD00
NOMESCO Finland
Fitting and preparation of total teeth prosthesis
29.1
10.2
14
*
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.3
10.2
93
341
R04.0
ICD-10 Finland
Epistaxis
2.1
10.2
123
512
SPAT1370
SPAT
Other health check-up
5.3
10.2
31
49
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.7
10.2
253
1344
A05
ICPC
Feeling ill
3.9
10.2
42
91
B82
ICPC
Anaemia other/unspecified
4.0
10.2
41
87
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.5
10.2
78
261
M53.1
ICD-10 Finland
Cervicobrachial syndrome
4.2
10.2
39
79
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.2
10.1
107
421
K40
ICD-10 Finland
Inguinal hernia
4.6
10.1
35
64
B01AB10
ATC
tinzaparin; parenteral
3.4
10.1
50
126
A10BB01
ATC
glibenclamide; oral
0.5
10.1
79
1261
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
0.1
10.1
*
302
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
3.1
10.1
55
149
R41.3
ICD-10 Finland
Other amnesia
3.1
10.1
57
157
WX212
NOMESCO Finland
Femoral plexus blockade
3.8
10.1
43
96
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
4.3
10.1
37
72
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
4.2
10.1
38
76
K05.0
ICD-10 Finland
Acute gingivitis
20.8
10.1
15
6
S76
ICPC
Skin infection other
3.7
10.0
44
101
F05
ICPC
Visual disturbance other
6.1
10.0
27
37
EBB10
NOMESCO Finland
Insertion of dental implant
36.0
10.0
13
*
K02.9
ICD-10 Finland
Dental caries, unspecified
9.8
10.0
20
17
J01MA14
ATC
moxifloxacin; systemic
2.1
9.9
114
465
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
2.9
9.9
62
184
J01MA12
ATC
levofloxacin; systemic
1.6
9.9
286
1582
B35.1
ICD-10 Finland
Tinea unguium
4.6
9.9
34
62
R03.0
ICD-10 Finland
Elevated blood-pressure reading, without diagnosis of hypertension
8.8
9.8
21
20
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.8
9.8
172
821
K80
ICPC
Cardiac arrhythmia NOS
3.8
9.8
41
90
D07AD01
ATC
clobetasol; topical
2.1
9.8
111
449
M05BA04
ATC
alendronic acid; oral
1.9
9.8
159
739
K22
ICPC
Risk factor cardiovascular disease
3.7
9.8
43
99
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.3
9.7
48
121
A91
ICPC
Abnormal result investigation NOS
4.5
9.7
34
63
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
7.4
9.7
23
26
SPE00
NOMESCO Finland
Fitting and preparation of metal structure partial teeth prosthesis
23.3
9.7
14
5
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.0
9.7
38
79
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
4.8
9.7
32
56
SPAT1240
SPAT
Therapeutic discussion
4.8
9.7
32
56
SAAPA
NOMESCO Finland
NA
+∞
9.7
10
*
WKPAL
NOMESCO Finland
NA
+∞
9.7
10
*
201
Kela drug reimbursment
Chronic cardiac insufficiency
0.5
9.7
99
1457
M19.0
ICD-10 Finland
Primary arthrosis of other joints
3.3
9.6
48
122
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
4.6
9.6
33
60
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.8
9.6
61
183
H40.0
ICD-10 Finland
Glaucoma suspect
2.6
9.6
68
218
K04.09
ICD-10 Finland
Pulpit UNS
14.8
9.6
16
9
SPAT1131
SPAT
Colonoscopy
5.3
9.6
29
46
S20
ICPC
Corn/callosity
6.0
9.6
26
36
S08
ICPC
Skin colour change
4.1
9.6
37
76
L89
ICPC
Osteoarthrosis of hip
6.3
9.5
25
33
S70.0
ICD-10 Finland
Contusion of hip
2.3
9.5
87
318
XCK00
NOMESCO Finland
Perimetry
2.2
9.5
93
354
B03BA03
ATC
hydroxocobalamin; parenteral
1.9
9.5
150
693
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.4
9.5
46
115
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
0.2
9.5
11
405
S09
ICPC
Infected finger/toe
5.6
9.4
27
40
NFB50
NOMESCO Finland
Primary total prosthetic replacement of hip joint using cement
2.4
9.4
82
294
A10BH05
ATC
linagliptin; oral
2.7
9.4
63
195
B02
ICD-10 Finland
Zoster [herpes zoster]
5.2
9.4
29
47
ECA10
NOMESCO Finland
Incision of gingiva
27.0
9.4
13
*
R03BA08
ATC
ciclesonide; inhalant
4.5
9.4
33
62
N04BC05
ATC
pramipexole; oral
2.3
9.4
86
315
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
2.7
9.4
66
211
FME20
NOMESCO Finland
Transvenous aortic valve replacement via femoral artery
8.0
9.3
21
22
K43
ICPC
Cardiovascular, Other diagnostic procedure
8.0
9.3
21
22
M47.9
ICD-10 Finland
Spondylosis, unspecified
3.3
9.3
46
117
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
4.5
9.3
32
59
WYA00
NOMESCO Finland
Screening and health check-up
13.3
9.2
16
10
SPAT1284
SPAT
Extensive health certificate
4.0
9.2
36
75
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
5.2
9.2
28
45
TQW80
NOMESCO Finland
Local dermatologic skincare
5.2
9.2
28
45
K30
ICD-10 Finland
Functional dyspepsia
2.7
9.2
61
188
B01AF03
ATC
edoxaban; oral
6.0
9.2
25
35
H53.1
ICD-10 Finland
Subjective visual disturbances
3.7
9.1
40
92
G47.3
ICD-10 Finland
Sleep apnoea
2.5
9.1
72
246
K99
ICPC
Cardiovascular disease other
3.3
9.1
45
114
G44.2
ICD-10 Finland
Tension-type headache
2.7
9.1
61
189
ND1BA
NOMESCO Finland
Wrist extensive X-ray examination
7.6
9.1
21
23
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
7.6
9.1
21
23
R06
ICPC
Nose bleed/epistaxis
4.2
9.1
34
68
K76
ICPC
Ischaemic heart dis without angina
4.1
9.1
35
72
SPAT1138
SPAT
Guidance concerning bowel function
4.1
9.1
35
72
H25.0
ICD-10 Finland
Senile incipient cataract
2.0
9.1
116
495
N02AC04
ATC
dextropropoxyphene; oral
0.4
9.0
36
729
K87
ICPC
Hypertension complicated
4.3
9.0
33
65
NF3AA
NOMESCO Finland
Femur X-ray examination
3.4
8.9
43
107
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
3.0
8.9
51
143
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
2.9
8.9
52
149
D02AX
ATC
Other emollients and protectives
4.5
8.9
31
58
J02AC01
ATC
fluconazole; systemic
1.7
8.8
216
1142
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
45.7
8.8
11
*
F03
ICPC
Eye discharge
4.1
8.8
34
70
ECA20
NOMESCO Finland
Biopsy of gingiva
16.6
8.8
14
7
H35.38
ICD-10 Finland
Preretinal fibrosis of the macula
4.8
8.8
29
51
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.7
8.8
181
908
SPAT1070
SPAT
Doppler ultrasound examination of blood flow in arteries of lower extremity
5.6
8.8
25
37
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.9
8.8
126
563
4402A
ICD-9 Finland
Atherosclerosis, Of native arteries of the extremities
0.2
8.8
12
405
SPAT1125
SPAT
Stoma care and guidance
3.4
8.8
41
100
D07AB08
ATC
desonide; topical
1.9
8.7
125
556
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.5
8.7
40
96
R4120
NOMESCO Finland
Occupational therapy
3.0
8.7
50
141
K03.11
ICD-10 Finland
Abrasion dentifrice of teeth
+∞
8.7
9
*
PLAK1
NOMESCO Finland
NA
+∞
8.7
9
*
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
+∞
8.7
9
*
D01AE15
ATC
terbinafine; topical
2.2
8.7
90
352
SPF02
NOMESCO Finland
Impression for dental prosthesis repair, restricted
83.0
8.7
10
*
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
83.0
8.7
10
*
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.8
8.6
148
702
S61.0
ICD-10 Finland
Open wound of finger(s) without damage to nail
3.7
8.6
37
84
AN4
HP
Balloon angioplasty and drug eluding stent
3.2
8.6
44
115
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
2.5
8.6
66
223
ZXC15
NOMESCO Finland
Use of photodynamic technique
4.8
8.6
28
49
S10
ICPC
Boil/carbuncle
4.8
8.6
28
49
XF600
NOMESCO Finland
Bloodpressure measurement
2.3
8.5
81
303
M35.3
ICD-10 Finland
Polymyalgia rheumatica
2.4
8.5
70
243
R29
ICPC
Respiratory symptom/complaint other
3.7
8.5
37
85
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
6.0
8.5
23
32
I84
ICD-10 Finland
Hemorrhoids
6.3
8.5
22
29
R60.9
ICD-10 Finland
Oedema, unspecified
2.8
8.5
53
158
I48.1
ICD-10 Finland
Persistent atrial fibrillation
4.9
8.5
27
46
SPAT1152
SPAT
Removal of foreign body from under the skin
7.3
8.5
20
23
S43.4
ICD-10 Finland
Sprain and strain of shoulder joint
7.3
8.5
20
23
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.0
8.5
33
69
M54.6
ICD-10 Finland
Pain in thoracic spine
4.0
8.5
33
69
TKC22
NOMESCO Finland
Catheterisation instruction
5.4
8.5
25
39
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
0.0
8.4
*
202
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.7
8.4
181
921
L02BB04
ATC
enzalutamide; oral
18.0
8.4
13
6
L75
ICPC
Fracture: femur
3.6
8.4
37
86
M71.2
ICD-10 Finland
Synovial cyst of popliteal space [Baker]
4.7
8.4
28
50
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
4.7
8.4
28
50
N18
ICD-10 Finland
Chronic kidney disease
4.7
8.4
28
50
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
2.9
8.3
50
146
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.1
8.3
98
404
A48
ICPC
General and Unspecified, Clarification/discussion RFE/demand
3.2
8.3
42
109
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.2
8.3
42
109
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
2.8
8.3
52
155
R07.0
ICD-10 Finland
Pain in throat
5.2
8.3
25
40
WF002
NOMESCO Finland
Radical radiotherapy
6.5
8.3
21
27
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
6.5
8.3
21
27
Z00.8
ICD-10 Finland
Other general examinations
2.7
8.2
56
176
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
7.0
8.2
20
24
HAHOM
NOMESCO Finland
NA
30.5
8.2
11
*
SCD02
NOMESCO Finland
Removal of tooth plaque or tartar
30.5
8.2
11
*
N06AX26
ATC
vortioxetine; oral
5.4
8.2
24
37
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
3.5
8.2
37
88
N05AD03
ATC
melperone; systemic
0.2
8.2
8
329
ACC51
NOMESCO Finland
Release of median nerve
3.3
8.2
41
106
163
Kela drug reimbursment
Abiraterone and enzalutamide
8.8
8.1
17
16
S01
ICD-10 Finland
Open wound of head
4.5
8.1
28
52
M03BC51
ATC
orphenadrine, combinations; systemic
1.7
8.1
159
788
R4135
NOMESCO Finland
Rehabilitation for hearing problems
3.0
8.1
47
134
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
2.6
8.1
58
187
R95
ICPC
Chron obstructive pulmonary disease
3.5
8.1
37
89
S00.0
ICD-10 Finland
Superficial injury of scalp
3.2
8.1
41
107
A62
ICPC
General and Unspecified, Administrative procedure
4.8
8.1
26
45
T92
ICPC
Gout
5.3
8.0
24
38
J01CA08
ATC
pivmecillinam; oral
1.5
8.0
356
2164
K00.09
ICD-10 Finland
Lack of teeth due to lack of dental development UNS
19.9
8.0
12
5
H02.1
ICD-10 Finland
Ectropion of eyelid
2.9
8.0
47
135
N05CF01
ATC
zopiclone; oral
1.4
8.0
550
3629
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
6.7
8.0
20
25
K13.78
ICD-10 Finland
Other change in the oral mucosa
15.4
8.0
13
7
SPAT1336
SPAT
Request for examination
3.5
8.0
37
90
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.9
8.0
116
521
G30
ICD-10 Finland
Alzheimer disease
2.8
8.0
50
149
M67.4
ICD-10 Finland
Ganglion
5.0
8.0
25
42
R51.81
ICD-10 Finland
Facial pain NOS
9.5
8.0
16
14
A02BC04
ATC
rabeprazole; oral
3.0
8.0
46
131
XF402
NOMESCO Finland
ECG with work load test
2.2
8.0
82
320
SPAT1276
SPAT
Outlining of treatment with patient or their family members
3.1
7.9
42
113
Z09
ICPC
Legal problem
41.5
7.9
10
*
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
4.7
7.9
26
46
F02
ICPC
Red eye
5.7
7.9
22
32
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
2.3
7.9
74
276
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.7
7.9
33
74
J01CF05
ATC
flucloxacillin; systemic
4.3
7.9
28
54
K59.0
ICD-10 Finland
Constipation
1.9
7.8
111
494
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
10.4
7.8
15
12
S01EC54
ATC
brinzolamide, combinations; ophthalmic
7.5
7.8
18
20
WX725
NOMESCO Finland
Noninvasive ventilation
4.9
7.8
25
43
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
3.1
7.8
41
110
E000006
ATC
NA
2.2
7.8
81
318
-30
ICPC
Medical examin/health eval complete
4.6
7.8
26
47
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.8
7.8
142
687
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
74.7
7.7
9
*
SPA60
NOMESCO Finland
Fitting of intermediary dental prosthesis structures, 1 to 3 units
74.7
7.7
9
*
AN2
HP
Balloon angioplasty, including several vessels
2.9
7.7
46
134
Y94.0
ICD-10 Finland
Accident at home
3.3
7.7
38
97
K05.08
ICD-10 Finland
Another acute gingivitis
+∞
7.7
8
*
SPF11
NOMESCO Finland
Fitting of dental prosthesis
+∞
7.7
8
*
C01AA05
ATC
digoxin; systemic
0.7
7.7
206
2424
UDQ12
NOMESCO Finland
Flexible laryngoscopy
4.3
7.7
28
55
-34
ICPC
Blood test
3.5
7.7
35
84
AA1XD
NOMESCO Finland
Other special CT of head and brain
22.8
7.7
11
*
CBB11
NOMESCO Finland
Resection of lax skin in upper eyelid
22.8
7.7
11
*
N02AX02
ATC
tramadol; systemic, rectal
1.4
7.7
484
3143
L81
ICPC
Injury musculoskeletal NOS
5.2
7.6
23
37
N87
ICPC
Parkinsonism
5.2
7.6
23
37
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
6.2
7.6
20
27
S90.0
ICD-10 Finland
Contusion of ankle
13.5
7.6
13
8
K10.3
ICD-10 Finland
Alveolitis of jaws
13.5
7.6
13
8
CBN30
NOMESCO Finland
Shortening of canthal ligament
7.9
7.6
17
18
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.6
7.6
227
1261
R09
ICPC
Sinus symptom/complaint
16.6
7.6
12
6
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.5
7.6
35
85
SPAT1257
SPAT
Teaching of medicine inhalation technique
3.8
7.6
31
68
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.5
7.6
58
194
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
3.4
7.5
36
90
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
3.0
7.5
43
121
M01AX17
ATC
nimesulide; oral
1.5
7.5
290
1707
AS4
HP
Physiological pacemaker insertion DDD (R)
3.3
7.5
37
95
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.9
7.5
30
65
R03DC03
ATC
montelukast; oral
2.0
7.5
88
365
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
1.9
7.5
117
539
L84
ICD-10 Finland
Corns and callosities
4.0
7.5
29
61
N05CF02
ATC
zolpidem; oral
1.9
7.5
113
513
-48
ICPC
Clarification/discussion RFE/demand
4.8
7.4
24
42
R00.2
ICD-10 Finland
Palpitations
3.2
7.4
37
96
I48.2
ICD-10 Finland
Chronic atrial fibrillation
3.2
7.4
37
96
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
5.2
7.4
22
35
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.2
7.4
22
35
L02AE04
ATC
triptorelin; parenteral
10.6
7.4
14
11
ZXH06
SPAT
NA
10.6
7.4
14
11
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
10.6
7.4
14
11
I21.9
ICD-10 Finland
Acute myocardial infarction, unspecified
0.4
7.4
36
674
CS494
NOMESCO Finland
Other visual field testing
7.5
7.4
17
19
A10AE05
ATC
insulin detemir; parenteral
2.4
7.4
63
225
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
27.7
7.3
10
*
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
27.7
7.3
10
*
L60.0
ICD-10 Finland
Ingrowing nail
4.0
7.3
28
58
P29
ICPC
Psychological sympt/compl other
5.5
7.3
21
32
WF003
NOMESCO Finland
Adjuvant radiotherapy
8.9
7.3
15
14
B07.9
ICD-10 Finland
Verruca simplex
5.8
7.3
20
29
N19
ICPC
Speech disorder
5.8
7.3
20
29
U14
ICPC
Kidney symptom/complaint
5.1
7.2
22
36
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
3.5
7.2
33
80
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
4.3
7.2
26
51
ZX080
NOMESCO Finland
Image guided radiotherapy
14.2
7.2
12
7
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
6.1
7.2
19
26
-1
SPAT
NA
6.1
7.2
19
26
M10.0
ICD-10 Finland
Idiopathic gout
2.8
7.2
46
140
NG2AA
NOMESCO Finland
Patella X-ray examination
7.8
7.2
16
17
F13
ICPC
Eye sensation abnormal
7.8
7.2
16
17
A50
ICPC
General and Unspecified, Medication/prescr/renewal
3.1
7.2
38
103
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.3
7.2
64
233
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
5.3
7.2
21
33
A10AE04
ATC
insulin glargine; parenteral
1.9
7.1
103
460
B35.3
ICD-10 Finland
Tinea pedis
4.2
7.1
26
52
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
5.0
7.1
22
37
S01.9
ICD-10 Finland
Open wound of head, part unspecified
3.2
7.1
36
95
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
3.2
7.1
36
95
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
2.5
7.1
53
178
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.1
7.1
80
325
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.6
7.1
31
73
SPF03
NOMESCO Finland
Impression for dental prosthesis repair, demanding
37.3
7.1
9
*
SPD05
NOMESCO Finland
Demanding fitting of total teeth prosthesis
37.3
7.1
9
*
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
3.1
7.0
37
100
H53.9
ICD-10 Finland
Visual disturbance, unspecified
5.9
7.0
19
27
D89
ICPC
Inguinal hernia
5.9
7.0
19
27
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
3.0
7.0
40
113
WVA30
SPAT
NA
8.3
7.0
15
15
Z08
ICPC
Social welfare problem
6.2
7.0
18
24
ZXC20
NOMESCO Finland
Use of chemical agents
3.1
7.0
36
96
S61.8
ICD-10 Finland
Open wound of other parts of wrist and hand
4.3
7.0
25
49
SPAT1273
SPAT
Structured assessment of psychoactive substance / tobacco use
10.8
7.0
13
10
F01
ICPC
Eye pain
7.4
7.0
16
18
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
3.5
6.9
31
74
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
1.9
6.9
107
490
SPAT1202
SPAT
Intra-articular injection
3.7
6.9
29
66
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
3.2
6.9
34
88
R23
ICPC
Voice symptom/complaint
12.5
6.9
12
8
R41.0
ICD-10 Finland
Disorientation, unspecified
2.0
6.9
89
382
WVA20
NOMESCO Finland
Medicine administration
5.7
6.9
19
28
K04.6
ICD-10 Finland
Periapical abscess with sinus
20.7
6.9
10
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.8
6.8
41
121
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
4.0
6.8
26
54
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
4.0
6.8
26
54
S01EC04
ATC
brinzolamide; ophthalmic
2.4
6.8
57
202
TQW40
NOMESCO Finland
Remowal of suture of skin
2.9
6.8
39
111
SPAT1246
SPAT
Screening of depression or other psychiatric problem
4.7
6.8
22
39
A54
ICPC
General and Unspecified, Repair/fix-suture/cast/prosth device
7.8
6.8
15
16
SPA45
NOMESCO Finland
Precision impression for dental prosthesis, demanding
+∞
6.8
7
*
K03.09
ICD-10 Finland
Abrasion of the teeth UNS
+∞
6.8
7
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.4
6.8
57
204
H28
ICPC
Limited function/disability (H)
5.2
6.8
20
32
GD1LA
NOMESCO Finland
GD
5.2
6.8
20
32
H01.0
ICD-10 Finland
Blepharitis
3.7
6.8
28
63
S01BC05
ATC
ketorolac; ophthalmic
1.7
6.8
138
691
TDA90
NOMESCO Finland
Removal wax from ear
4.5
6.7
23
43
4148X
ICD-9 Finland
Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]
0.2
6.7
7
276
S01EE03
ATC
bimatoprost; ophthalmic
3.1
6.7
35
94
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
3.4
6.7
31
76
S17
ICPC
Abrasion/scratch/blister
3.9
6.7
26
55
J31.0
ICD-10 Finland
Chronic rhinitis
3.5
6.7
30
72
E000007
ATC
NA
3.0
6.7
38
107
S77
ICPC
Malignant neoplasm of skin
4.9
6.7
21
36
S01.8
ICD-10 Finland
Open wound of other parts of head
4.9
6.7
21
36
R39.1
ICD-10 Finland
Other difficulties with micturition
2.9
6.7
39
113
N06DA03
ATC
rivastigmine; oral, transdermal
1.7
6.7
126
619
D07AA02
ATC
hydrocortisone; topical
1.7
6.6
153
794
F00.9
ICD-10 Finland
Dementia in Alzheimer disease, unspecified
3.7
6.6
28
64
DHB00
NOMESCO Finland
Excision of lesion of external nose
4.6
6.6
22
40
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
3.9
6.6
26
56
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
3.1
6.6
34
91
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
4.2
6.6
24
48
D10
ICPC
Vomiting
4.2
6.6
24
48
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.0
6.6
77
319
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
2.0
6.6
77
319
F00
ICD-10 Finland
Dementia in Alzheimer disease
8.3
6.6
14
14
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
8.3
6.6
14
14
L88
ICPC
Rheumatoid/seropositive arthritis
6.2
6.6
17
23
N30.9
ICD-10 Finland
Cystitis, unspecified
1.9
6.6
97
440
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
2.1
6.6
70
279
F06.7
ICD-10 Finland
Mild cognitive disorder
2.6
6.6
46
149
M15.8
ICD-10 Finland
Other polyarthrosis
11.1
6.5
12
9
GD1AA
SPAT
NA
7.3
6.5
15
17
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
4.7
6.5
21
37
G45.4
ICD-10 Finland
Transient global amnesia
4.7
6.5
21
37
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
0.2
6.5
6
256
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
2.7
6.5
43
135
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
4.5
6.5
22
41
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
1.8
6.5
100
461
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
2.9
6.4
37
106
SPAT1283
SPAT
Restricted health certificate
3.5
6.4
28
66
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
3.5
6.4
28
66
C44.29
ICD-10 Finland
Malignant tumor of the skin of the outer ear and in the outer ear canal other or unspecified histology
9.0
6.4
13
12
R20.2
ICD-10 Finland
Paraesthesia of skin
3.6
6.4
27
62
C01DA14
ATC
isosorbide mononitrate; oral
1.3
6.4
536
3623
CKW99
NOMESCO Finland
Other operation on choroid, vitreous body and retina
5.9
6.4
17
24
-64
ICPC
Encounter/prob initiated by provider
5.9
6.4
17
24
CBB30
NOMESCO Finland
Excision of lesion of eyelid
2.9
6.4
37
107
I20
ICD-10 Finland
Angina pectoris
3.0
6.4
36
101
Y94.8
ICD-10 Finland
Other leisure activity accident
4.4
6.4
22
42
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
0.1
6.4
*
156
L95
ICPC
Osteoporosis
6.3
6.3
16
21
C09CA03
ATC
valsartan; oral
2.0
6.3
81
347
J06
ICD-10 Finland
Acute upper respiratory infections of multiple and unspecified sites
6.9
6.3
15
18
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.0
6.3
79
336
N06AB10
ATC
escitalopram; oral
1.8
6.3
116
565
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
3.3
6.3
30
76
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.4
6.3
18
28
N30
ICD-10 Finland
Cystitis
2.4
6.3
51
180
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
2.4
6.3
51
180
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
1.5
6.3
255
1515
S93.4
ICD-10 Finland
Sprain and strain of ankle
3.4
6.3
29
72
R1260
NOMESCO Finland
Evaluation of communicative skills
3.4
6.3
29
72
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
4.5
6.3
21
39
K01
ICPC
Heart pain
4.5
6.3
21
39
S26
ICPC
Fear of cancer of skin
10.0
6.3
12
10
I44.7
ICD-10 Finland
Left bundle-branch block, unspecified
3.8
6.2
25
55
G04BD09
ATC
trospium; oral
2.9
6.2
36
104
A06AD11
ATC
lactulose; oral
1.4
6.2
394
2545
CA1TM
NOMESCO Finland
Calculation of intraocular lens power
5.7
6.2
17
25
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.6
6.2
43
137
SPF31
NOMESCO Finland
Denture relining/rebasing
33.1
6.2
8
*
L02BB03
ATC
bicalutamide; oral
1.9
6.2
95
435
PD5BD
NOMESCO Finland
Extensive CT of aorta
3.3
6.2
29
73
M02AA10
ATC
ketoprofen; topical
1.6
6.2
168
914
L92
ICPC
Shoulder syndrome
8.3
6.2
13
13
SPAT1088
SPAT
Blood transfusion
8.3
6.2
13
13
I83
ICD-10 Finland
Varicose veins of lower extremities
6.1
6.2
16
22
SPAT1168
SPAT
Catheterisation training
6.1
6.2
16
22
ZQZ00
NOMESCO Finland
Treatment of several skin areas
4.6
6.1
20
36
-43
ICPC
Other diagnostic procedure
4.6
6.1
20
36
SPAT1307
SPAT
Psychosocial counselling and guidance
4.6
6.1
20
36
WXQ41
NOMESCO Finland
Photodynamic therapy of head and neck
11.4
6.1
11
8
SPAT1147
SPAT
Destruction of skin lesion with external methods
6.6
6.1
15
19
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
6.1
78
336
L43.8
ICD-10 Finland
Other lichen planus
7.3
6.1
14
16
N80
ICPC
Head injury other
5.2
6.1
18
29
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
5.2
6.1
18
29
R5110
SPAT
NA
4.2
6.1
22
44
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
4.0
6.1
23
48
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.0
6.1
23
48
M72.0
ICD-10 Finland
Palmar fascial fibromatosis [Dupuytren]
2.3
6.1
52
187
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
2.2
6.1
57
214
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
3.5
6.1
27
65
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.9
6.1
85
377
A07AA02
ATC
nystatin; oral
1.9
6.1
81
353
-2
ICPC
NA
3.3
6.1
29
74
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
2.1
6.1
69
284
M70.2
ICD-10 Finland
Olecranon bursitis
3.6
6.0
26
61
J02AC02
ATC
itraconazole; systemic
1.7
6.0
112
548
-53
ICPC
Instrument/catheter/intubate/dilate
18.7
6.0
9
*
ECB20
NOMESCO Finland
Oral alveoplasty
18.7
6.0
9
*
A02BD03
ATC
lansoprazole, amoxicillin and metronidazole; systemic
1.8
6.0
98
460
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
3.2
6.0
30
79
M76.6
ICD-10 Finland
Achilles tendinitis
4.5
6.0
20
37

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42870588) Differential panel, method unspecified - Blood
13996
52475
1.54
318.96
6.2
5.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
9909
34335
1.62
314.24
1.6
1.5
nmol/l
20.2
20.1
0.16
8554
29340
(3002385) Erythrocyte distribution width [Ratio]
31280
139232
1.55
313.56
19.6
15.8
%
13.7
13.7
0.88
30632
136027
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
15693
60532
1.52
312.45
4.0
3.5
ng/l
85.6
72.3
0.17
11054
40958
(3035941) MCH [Entitic mass]
42015
188787
5.26
307.65
23.9
18.5
pg
30.3
30.3
9.30
41509
185402
(3032080) INR in Blood by Coagulation assay
17009
63604
1.61
307.65
10.3
8.7
inr
1.3
1.3
0.34
4931
17529
(3031040) Bacteria [#/volume] in Urine by Automated count
26544
103732
1.80
307.65
4.9
4.1
e6/l
1118.7
1436.1
0.54
374
1478
(3013707) Erythrocyte sedimentation rate by Westergren method
29475
115680
1.96
307.65
4.3
3.6
mm/h
12.4
12.5
0.73
27352
106262
(3009261) Glucose [Presence] in Urine by Test strip
19629
78468
1.52
307.65
3.9
3.4
estimate
0.0
0.0
0.03
3724
13016
(3013650) Neutrophils [#/volume] in Blood by Automated count
22885
92102
1.58
307.65
9.6
8.2
e9/l
4.2
4.2
2.75
20070
79319
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
35293
148757
2.16
307.65
6.0
5.3
mmol/mol
39.9
39.8
1.27
32722
137022
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
18841
73787
1.55
307.65
4.4
3.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
20010
78466
1.57
307.65
6.2
5.4
e9/l
0.6
0.6
0.39
17346
66966
(3020564) Creatinine [Moles/volume] in Serum or Plasma
40470
177778
3.44
307.65
18.7
15.0
umol/l
80.3
78.5
17.09
40456
177665
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
12731
46494
1.57
307.65
2.2
2.0
u/l
214.8
227.9
0.44
11961
43443
(40768804) Tissue Pathology biopsy report
16180
62345
1.53
307.65
2.2
2.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
18817
74030
1.54
307.65
6.4
5.5
%
2.8
2.8
0.21
17448
68918
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
20461
77701
1.66
307.65
7.4
6.1
mmol/l
1.2
1.2
0.87
17228
65310
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
16933
63488
1.60
307.65
2.1
1.9
pmol/l
95.1
94.4
0.93
9017
33303
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
40453
178578
3.35
307.65
11.2
9.1
u/l
26.3
26.9
5.16
39115
171540
(3013826) Glucose [Moles/volume] in Serum or Plasma
23817
93713
1.67
307.65
5.1
4.5
mmol/l
6.7
6.8
7.11
22354
87405
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
35797
155620
2.02
307.65
14.9
12.4
ml/min/173m2
79.7
80.9
20.12
29891
127534
(3001122) Ferritin [Mass/volume] in Serum or Plasma
17304
67233
1.53
307.65
2.9
2.7
ug/l
133.7
135.8
0.33
15897
62305
(3026361) Erythrocytes [#/volume] in Blood
42019
188852
5.27
307.65
24.0
18.6
e12/l
4.5
4.5
32.00
40965
182193
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
29653
120039
1.84
307.65
4.0
3.6
pmol/l
14.8
14.8
1.21
26935
108791
(3010813) Leukocytes [#/volume] in Blood
42027
188895
5.29
307.65
24.1
18.7
e9/l
6.8
6.8
1.93
40978
182206
(3037467) Urinalysis macro (dipstick) panel - Urine
27693
109134
1.83
307.65
4.7
3.9
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
41995
188626
5.22
307.65
24.1
18.6
e9/l
247.0
250.3
19.97
41069
182601
(3022096) Basophils/100 leukocytes in Blood
18212
72064
1.51
307.65
6.4
5.6
%
0.7
0.7
0.03
16914
67119
(3018010) Neutrophils/100 leukocytes in Blood
19082
75579
1.53
307.65
6.3
5.4
%
57.6
57.7
0.75
17739
70667
(3002030) Lymphocytes/100 leukocytes in Blood
19376
76837
1.53
307.65
6.5
5.6
%
27.5
27.5
0.00
17928
71603
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
16430
63112
1.54
307.65
2.3
2.1
nmol/l
78.0
76.6
7.12
14689
56476
(3021601) Nitrite [Presence] in Urine by Test strip
19408
77570
1.51
307.65
5.1
4.7
estimate
0.0
0.0
0.22
3849
13368
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
35921
155705
2.06
307.65
4.0
3.6
mmol/l
1.3
1.3
0.18
32903
142461
(3013115) Eosinophils [#/volume] in Blood
20794
81354
1.60
307.65
6.4
5.6
e9/l
0.2
0.2
0.66
18311
70241
(3035350) Ketones [Presence] in Urine by Test strip
19401
77381
1.52
307.65
3.9
3.4
estimate
0.0
0.0
0.90
3766
13072
(3023103) Potassium [Moles/volume] in Serum or Plasma
39471
170288
3.06
307.65
19.0
15.2
mmol/l
4.0
4.0
17.13
38562
164736
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
37105
161205
2.24
307.65
4.5
4.0
mmol/l
1.4
1.5
11.87
34267
148297
(3000963) Hemoglobin [Mass/volume] in Blood
42025
188928
5.27
307.65
24.2
18.7
g/l
135.0
135.8
22.13
41519
185539
(3019069) Monocytes/100 leukocytes in Blood
18924
74449
1.54
307.65
6.8
5.7
%
8.7
8.7
0.26
17640
69613
(3024731) MCV [Entitic volume]
42015
188831
5.25
307.65
24.0
18.6
fl
91.1
90.9
25.57
41509
185439
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
21033
81955
1.61
307.65
6.4
5.8
umol/l
11.7
12.2
4.30
19931
77512
(3044889) 12 lead EKG panel
26956
112633
1.60
307.65
4.1
3.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
35281
147577
2.20
307.65
4.9
4.2
mu/l
2.2
2.1
0.35
32377
134250
(3019550) Sodium [Moles/volume] in Serum or Plasma
39388
169688
3.04
307.65
18.9
15.1
mmol/l
139.6
139.6
0.04
38542
164561
(40761511) CBC panel - Blood by Automated count
39590
174525
2.84
307.65
15.5
12.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
30482
123290
1.90
307.65
7.9
6.9
u/l
79.1
79.6
0.81
28724
115698
(3006315) Basophils [#/volume] in Blood
20123
78850
1.58
307.65
6.2
5.4
e9/l
0.0
0.0
0.25
17460
67222
(3019309) Folate [Moles/volume] in Red Blood Cells
8601
28367
1.69
307.65
1.8
1.7
nmol/l
1140.2
1164.8
1.50
6525
21019
(3024561) Albumin [Mass/volume] in Serum or Plasma
17698
68651
1.54
307.65
5.2
4.5
g/l
35.3
35.2
1.15
16379
63321
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
38145
165693
2.48
307.65
5.0
4.4
mmol/l
2.7
2.8
38.83
35236
152281
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
25761
109653
1.50
307.65
3.3
2.8
u/l
50.4
49.1
1.19
23966
102297
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
18598
70192
1.63
307.65
6.6
5.7
mmol/l
1.2
1.2
2.62
16849
63177
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
38596
166346
2.70
307.65
16.4
13.1
mg/l
23.9
25.6
16.24
31449
130544
(3019198) Lymphocytes [#/volume] in Blood
20556
81074
1.57
307.65
6.2
5.4
e9/l
1.9
1.9
0.22
18108
70490
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
37409
162447
2.30
307.65
4.5
4.0
mmol/l
4.6
4.7
48.54
34741
150178
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
37088
156435
2.48
307.65
4.8
4.1
mmol/l
6.0
5.9
1.05
33910
141954
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
13094
47628
1.59
307.65
2.6
2.5
u/l
57.3
59.9
3.58
12129
43887
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
11081
38104
1.66
307.65
2.3
2.2
mg/l
3.0
3.0
2.43
9420
32226
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
12157
44455
1.56
306.60
3.3
2.9
ng/l
1686.2
1676.0
0.07
10437
38014
(3009508) Creatinine [Moles/volume] in Urine
12743
47620
1.53
287.73
3.3
3.1
mmol/l
7.5
7.8
9.46
10741
39569
(3018418) pH of Serum or Plasma
12165
45242
1.53
278.90
4.4
3.7
ph
7.4
7.4
0.13
2356
8166
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
14494
55995
1.49
277.28
5.1
4.6
ug/l
3.9
3.5
0.44
12997
50011
(3026008) Bacteria identified in Urine by Culture
12261
45936
1.51
269.77
3.3
3.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
34262
157642
1.54
261.65
17.4
13.9
%
39.7
39.9
5.01
23762
117472
(3020682) Albumin/Creatinine [Ratio] in Urine
12474
47372
1.49
253.93
4.0
3.8
mg/mmol
11.1
9.4
0.58
7928
30274
(3012516) Albumin [Mass/volume] in Urine
11878
44723
1.50
251.51
3.3
3.1
mg/l
385.4
352.7
0.32
7608
28360
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
24105
103960
1.43
249.23
3.0
2.8
—
—
—
0
0
(3013512) EKG study
11740
44323
1.49
243.79
4.2
3.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
11716
44274
1.49
241.76
4.5
4.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
8992
32150
1.55
239.63
1.7
1.6
pmol/l
23675053.5
34223616.2
1.00
7413
26409
(3021589) Normoblasts [#/volume] in Blood
17247
70612
1.42
231.48
10.4
8.9
e9/l
0.0
0.0
1.38
14177
57013
(3018095) Leukocytes [#/volume] in Urine
14327
56713
1.44
230.88
4.0
3.5
e6/l
91.7
116.0
2.48
10469
39540
(3015377) Calcium [Moles/volume] in Serum or Plasma
13441
52742
1.45
225.56
3.3
3.3
mmol/l
2.4
2.4
1.57
11637
45777
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
10235
38086
1.50
224.37
1.7
1.6
mmol/l
1.4
1.4
0.98
8692
31854
(3002582) Erythrocytes [#/volume] in Urine
12482
48344
1.46
223.89
3.6
3.1
e6/l
70.6
116.0
3.27
9805
36544
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
7231
24939
1.59
222.92
1.9
1.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
8940
32396
1.52
221.63
2.8
2.5
e6/l
4.9
5.5
4.73
7846
28272
(3000494) Fungus identified in Specimen by Culture
4993
15768
1.71
216.06
1.5
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
12989
51027
1.44
213.91
3.5
3.0
u/l
34.2
35.0
0.22
12283
48251
(3029937) Albumin [Presence] in Urine by Test strip
10677
40409
1.47
213.38
4.3
3.7
estimate
0.0
0.0
0.17
3690
12657
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
8547
30908
1.52
212.62
1.3
1.2
u/ml
1.8
1.8
0.11
2239
8473
(3030467) Casts [#/volume] in Urine by Automated count
11445
43998
1.45
210.63
3.4
3.0
e6/l
0.4
0.5
3.45
8840
32502
(3015736) pH of Urine
14949
60742
1.40
200.58
3.7
3.2
ph
5.8
5.7
—
9
76
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
14886
60446
1.40
200.47
4.1
3.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
11087
42827
1.44
196.13
3.4
3.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
11459
44844
1.42
187.10
4.5
4.0
%
21.9
22.0
0.40
5567
21137
(3026493) Urate [Moles/volume] in Serum or Plasma
10835
42179
1.42
180.92
2.8
2.5
umol/l
3493.7
6139.9
8.95
9312
36789
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
6758
23965
1.53
180.13
1.3
1.2
iu/ml
32.4
39.9
2.01
2054
7656
(3044640) Blood type and Crossmatch panel - Blood
12777
51359
1.39
176.80
2.6
2.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
6344
22326
1.54
174.45
1.3
1.2
u/ml
11.5
12.5
0.46
2337
9047
(3003338) MCHC [Mass/volume]
31634
146867
1.39
173.07
20.9
16.3
g/l
332.5
332.5
0.14
31397
145378
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
8162
30609
1.45
163.78
4.0
3.6
ng/l
381.5
591.3
3.70
6490
24081
(3022948) Iron [Moles/volume] in Serum or Plasma
6827
24755
1.49
161.98
2.6
2.3
umol/l
12.8
12.9
0.46
6264
22878
(3026782) Osmolality of Urine
8235
31025
1.45
160.92
3.0
2.7
mosm/kgh2o
547.0
554.0
1.58
7049
26480
(3019150) Specific gravity of Urine by Refractometry
8667
33095
1.43
157.02
4.4
3.8
kg/l
1.0
1.0
1.97
1302
5001
(3007164) IgA [Mass/volume] in Serum or Plasma
7477
27908
1.45
152.29
1.5
1.4
g/l
2.5
2.5
0.41
4486
17576
(3004789) Transferrin [Mass/volume] in Serum or Plasma
6317
22861
1.49
150.08
2.6
2.3
g/l
2.3
2.3
0.78
5799
21067
(40758558) Short blood count panel - Blood
10174
40228
1.39
150.01
7.1
6.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
5997
21477
1.50
149.82
2.1
1.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
9796
38666
1.39
145.07
2.5
2.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
9243
36190
1.39
143.27
3.9
3.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
5895
21237
1.49
142.45
27.8
24.6
inr
1.4
1.4
0.03
835
2866
(3012095) Magnesium [Moles/volume] in Serum or Plasma
6737
24987
1.45
140.47
3.7
3.1
mmol/l
0.8
0.8
0.34
6283
23112
(3027945) Reticulocytes/100 erythrocytes in Blood
5020
17541
1.53
139.81
2.6
2.3
%
1.8
1.8
0.46
4403
15359
(3007853) Bacteria identified in Skin by Aerobe culture
5082
17813
1.53
139.51
1.8
1.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
5891
21348
1.48
137.89
2.7
2.4
%
22.4
22.5
0.14
4930
18399
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
8761
34293
1.39
134.70
1.9
1.7
mg/l
1.2
1.3
0.93
6629
26571
(3048689) Calprotectin [Mass/mass] in Stool
4845
16940
1.53
134.13
2.3
2.4
ug/g
137.3
143.2
0.46
3798
13525
(3019225) pH of Specimen
4284
14589
1.56
133.30
4.7
3.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
5534
20003
1.48
130.53
1.2
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
4912
17369
1.51
128.65
1.8
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
4908
17430
1.50
125.73
1.8
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
3770
12716
1.57
121.61
2.6
2.5
e9/l
68.4
69.4
0.67
2904
9338
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
7065
27179
1.40
118.14
3.0
2.7
e6/l
1.0
1.3
2.11
4168
14965
(3003458) Phosphate [Moles/volume] in Serum or Plasma
5528
20356
1.45
117.56
6.7
5.0
mmol/l
1.0
1.0
0.50
5124
18767
(3022621) pH of Urine by Test strip
2867
9136
1.65
116.11
3.0
2.9
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
3807
13025
1.55
115.09
3.1
2.9
ng/l
222.3
245.3
1.87
3434
11885
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
6569
25058
1.41
114.97
1.5
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
3317
11033
1.59
113.09
4.1
3.7
%
0.7
0.7
0.24
772
2425
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
4990
18148
1.46
112.75
4.6
4.2
%
32.6
32.2
1.54
3572
11700
(3041096) Erythrocytes [Presence] in Urine by Automated
10347
42719
1.32
108.57
3.5
3.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
3606
12354
1.54
108.00
4.3
3.9
%
1.0
0.9
0.71
1060
3455
(3045414) Leukocytes [Presence] in Urine
2021
5966
1.77
107.26
2.0
1.8
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
4914
18027
1.45
105.65
4.3
3.9
u/l
241.8
249.9
2.95
4631
16976
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
7364
29048
1.36
104.18
3.0
3.1
mmol/l
2.5
2.5
0.75
6364
25223
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
8178
32847
1.34
102.71
3.1
2.9
ug/l
0.8
0.8
0.97
5568
20655
(3037522) Nuclear Ab [Titer] in Serum
5316
19893
1.42
102.48
1.3
1.3
titre
507.1
532.3
0.42
1086
3956
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
6603
25724
1.37
100.51
3.2
2.8
e6/l
2.3
2.7
2.58
3737
13632
(3036481) Cortisol [Moles/volume] in Serum or Plasma
3720
13043
1.51
99.79
2.2
2.2
nmol/l
368.0
381.5
3.51
3387
12023
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
3837
13554
1.50
99.31
2.4
2.2
ug/l
6.9
7.4
0.84
3301
11542
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
3256
11112
1.54
98.80
4.1
3.5
ng/l
93.9
89.4
1.71
2770
9511
(3017732) Neutrophils [#/volume] in Blood
2971
9942
1.57
98.17
3.1
2.7
e9/l
4.0
4.3
5.28
2321
7435
(3018677) aPTT in Platelet poor plasma by Coagulation assay
6347
24666
1.38
97.79
2.4
2.0
s
29.9
30.0
0.31
6165
23967
(3021440) Promyelocytes/100 leukocytes in Blood
3413
11812
1.52
97.14
4.3
3.9
%
0.2
0.1
0.64
989
3201
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
4308
15671
1.46
96.15
3.7
3.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
3151
10739
1.55
96.08
1.2
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
3530
12336
1.51
95.99
3.6
3.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
4563
16863
1.43
93.51
1.7
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
3200
11024
1.53
92.83
4.3
4.0
%
0.1
0.2
1.29
820
2672
(3020630) Protein [Mass/volume] in Serum or Plasma
3594
12708
1.49
92.23
2.7
2.3
g/l
66.3
66.4
0.23
3232
11451
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
3212
11108
1.52
91.49
1.7
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
2995
10211
1.54
90.98
2.4
2.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
3380
11861
1.50
89.84
2.7
2.6
ml/min/173m2
64.6
65.4
0.51
1375
4782
(3014051) Protein [Presence] in Urine by Test strip
1080
2737
2.05
89.70
2.3
2.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
8545
35236
1.30
87.11
4.9
3.9
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
3863
14178
1.44
81.46
8.3
5.9
mmol/l
10.2
10.3
0.40
3674
13360
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
2329
7702
1.58
80.41
2.5
2.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
6640
26691
1.33
80.38
1.9
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
5596
21933
1.35
80.16
1.7
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
2689
9216
1.53
79.40
1.2
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
2855
9915
1.51
79.31
4.3
3.8
kpa
5.1
5.2
0.69
2620
9116
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
1949
6187
1.65
79.30
2.1
1.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
669
1460
2.37
79.12
1.4
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
3401
12252
1.46
78.94
4.4
3.4
mmol/l
1.2
1.2
0.12
2965
10679
(3005719) IgG [Mass/volume] in Serum or Plasma
3098
10957
1.49
78.85
2.9
2.5
g/l
10.5
10.6
0.54
2828
9982
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
1876
5908
1.66
78.68
4.7
4.4
mmol/l
24.7
24.7
0.01
1718
5397
(3009343) pH of Capillary blood
2821
9790
1.51
78.61
4.3
3.8
ph
7.4
7.4
0.03
330
1284
(3033658) Prothrombin time (PT) actual/Normal
9983
42564
1.26
76.59
4.3
3.8
%
88.3
89.0
1.79
9729
41495
(4010399)
2919
10259
1.49
76.52
1.4
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
4680
17977
1.38
75.71
3.0
2.6
umol/l
8.3
9.5
2.60
4039
15646
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
2645
9131
1.52
75.43
1.7
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
2723
9479
1.51
74.66
4.3
3.8
mmol/l
1.6
1.8
1.59
2018
6939
(40761536) Microorganisms panel - Urine sediment
3447
12596
1.44
74.04
4.2
3.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
3871
14465
1.41
73.51
2.3
2.2
g/l
0.2
0.2
0.12
3599
13316
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
1778
5659
1.64
71.49
1.9
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
2101
6972
1.57
71.30
4.4
4.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
4933
19417
1.34
67.76
8.0
6.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
2616
9273
1.48
65.42
1.5
1.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
2435
8527
1.49
64.62
1.9
1.8
g/l
1.3
1.3
0.48
2222
7737
(3016502) Oxygen saturation in Arterial blood
4229
16423
1.36
63.12
7.8
7.5
%
95.8
95.3
4.59
4063
15824
(3005322) IgE [Units/volume] in Serum or Plasma
2449
8635
1.48
62.81
1.3
1.3
u/ml
212.1
267.5
1.87
2251
8005
(3027801) Oxygen [Partial pressure] in Arterial blood
4715
18656
1.33
62.14
7.3
7.1
kpa
12.3
12.3
0.15
4497
17720
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
4788
18996
1.33
61.93
1.8
1.7
%
1.5
1.4
7.74
4164
16895
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
4715
18669
1.33
61.82
7.3
7.1
kpa
5.1
5.1
1.38
4495
17734
(3003396) Base excess in Arterial blood by calculation
4703
18633
1.33
61.37
7.4
7.0
mmol/l
1.1
1.0
0.62
3655
14572
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
3469
13138
1.39
60.32
2.0
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
3846
14831
1.36
59.84
2.0
1.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
4385
17256
1.34
59.80
1.3
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
10361
45379
1.23
59.48
1.4
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
2083
7204
1.51
58.54
1.6
1.6
g/l
1.5
1.6
0.96
1769
6110
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
1121
3334
1.74
57.66
1.7
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
1087
3207
1.76
57.46
1.8
1.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
1592
5214
1.59
56.91
1.1
1.1
u/ml
1.2
9.6
0.99
25
80
(3019060) Gas panel - Arterial blood
2805
10340
1.42
56.86
5.1
4.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
3862
15051
1.35
55.94
8.2
7.8
g/l
120.8
122.1
3.10
3715
14538
(3008152) Bicarbonate [Moles/volume] in Arterial blood
2654
9752
1.42
54.70
7.1
6.8
mmol/l
24.6
24.6
0.11
2474
9105
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
3816
14896
1.34
54.62
2.6
2.4
u/l
39.4
52.1
1.23
3280
12757
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
620
1559
2.06
52.64
2.1
1.9
mg/l
26.1
25.8
0.05
185
331
(3002256) Pathology report gross observation
5104
20891
1.29
51.89
1.3
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
4170
16620
1.32
51.61
1.6
1.7
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
1391
4517
1.60
51.48
6.9
5.4
mmol/l
1.3
1.3
1.24
1239
3968
(3025941) Bacteria identified in Stool by Culture
2366
8613
1.43
51.23
1.3
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
1093
3340
1.70
51.11
1.6
1.6
e6/l
15228.6
14197.7
0.20
788
2383
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
1788
6164
1.51
50.91
2.0
1.9
ug/l
2.4
2.4
0.04
1540
5387
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
1204
3792
1.65
50.30
1.4
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
1266
4047
1.62
49.91
1.4
1.4
ug/g
274.5
267.9
0.49
751
2387
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
974
2916
1.73
48.98
1.4
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
1514
5097
1.54
48.02
2.7
2.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
2915
11159
1.36
47.00
1.5
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
905
2712
1.73
45.38
6.6
3.8
iu/ml
1587.6
1596.6
0.00
150
310
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
717
2003
1.85
45.25
1.4
1.3
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
1011
3128
1.67
45.19
7.9
6.3
mmol/l
105.0
105.1
0.18
906
2811
(3039000) Anion gap in Blood
1010
3128
1.67
44.98
7.9
6.3
mmol/l
11.1
11.4
1.96
905
2811
(3037121) Protein [Mass/volume] in Urine
1509
5157
1.52
44.70
3.4
3.0
g/l
0.4
0.3
0.98
621
2439
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
2279
8448
1.41
44.49
10.3
9.5
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
1764
6235
1.47
44.43
5.9
4.6
%
0.9
0.9
2.94
1653
5861
(3049717) Cytology report of Urine Cyto stain
1730
6110
1.47
43.74
2.7
2.8
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
225
381
3.04
42.79
36.2
32.2
ug/l
7.5
7.0
2.24
205
341
(3015171) Extractable nuclear Ab [Units/volume] in Serum
1543
5349
1.50
42.73
1.2
1.2
u/ml
1.1
0.7
0.60
142
505
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
806
2380
1.75
42.54
1.5
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
1340
4512
1.54
42.45
1.3
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
1947
7087
1.43
42.03
1.1
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
861
2616
1.70
41.14
1.3
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
869
2649
1.70
41.04
1.6
1.6
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
1771
6376
1.44
40.54
5.9
4.5
%
1.6
1.7
0.25
1656
5999
(4024509)
455
1129
2.08
40.10
1.5
1.6
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
4982
20939
1.25
39.87
7.2
7.0
mmol/l
104.4
104.5
0.45
4880
20492
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
2384
9088
1.37
39.28
3.2
3.4
pmol/l
4.5
4.5
0.60
2121
8089
(3042733) HLA Ab [Presence] in Serum
175
267
3.37
39.03
5.0
4.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
3168
12618
1.31
38.87
2.3
2.1
nmol/l
12.3
12.9
3.76
2788
11293
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
629
1772
1.83
38.75
1.4
1.3
—
—
—
0
0
(3000492) Spirometry study
3692
15015
1.29
38.74
1.5
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
807
2454
1.70
38.47
1.4
1.2
u/ml
266.3
262.3
0.14
520
1569
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
693
2022
1.77
38.13
3.6
2.1
u/ml
2666.9
1784.4
0.28
43
101
(3014111) Lactate [Moles/volume] in Serum or Plasma
3626
14756
1.28
37.81
7.1
6.9
mmol/l
1.3
1.4
2.03
3490
14109
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1669
6029
1.44
37.51
2.3
2.0
g/l
7.4
7.4
0.12
1227
4459
(3009466) Valproate [Moles/volume] in Serum or Plasma
671
1949
1.78
37.48
5.2
4.4
umol/l
356.5
359.9
0.22
569
1653
(40760888) Immunoglobulin light chains.free panel - Serum
1067
3509
1.57
37.47
3.7
2.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
1196
4040
1.53
37.36
1.3
1.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
1383
4822
1.49
37.24
3.5
2.8
mg/l
45.0
44.6
0.03
1108
3929
(3034860) Kappa light chains.free [Mass/volume] in Serum
1384
4828
1.49
37.17
3.5
2.8
mg/l
55.5
78.7
1.00
1105
3929
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1664
6020
1.44
37.09
2.3
2.0
g/l
3.8
3.9
1.07
1180
4246
(3021788) Differential panel - Synovial fluid
820
2530
1.68
37.09
1.5
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
809
2488
1.68
37.03
1.8
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1665
6028
1.43
36.97
2.3
2.0
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
863
2703
1.65
36.89
1.5
1.3
u/ml
20.2
16.7
0.35
13
47
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1561
5586
1.45
36.87
2.4
2.1
g/l
3.1
3.1
0.18
1204
4377
(3010375) cycloSPORINE [Mass/volume] in Blood
242
467
2.67
36.85
25.9
26.5
ug/l
118.8
108.9
1.38
199
404
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
1345
4692
1.49
36.13
3.5
2.8
ratio
2.2
5.2
1.01
109
310
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
1227
4205
1.51
35.88
1.8
1.7
—
—
—
0
0
(3012544) pH of Venous blood
3938
16299
1.26
35.71
4.6
3.5
ph
7.4
7.4
0.16
22
75
(3000330) Specific gravity of Urine by Test strip
2058
7784
1.37
35.54
3.6
3.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1561
5633
1.44
35.27
2.3
2.0
g/l
10.3
10.3
0.02
1291
4761
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
863
2739
1.63
35.06
1.6
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
1254
4356
1.49
34.39
1.6
1.6
iu/ml
5.7
7.3
0.12
265
1051
(3044941) Cell count panel - Synovial fluid
706
2144
1.70
33.87
1.4
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
1906
7213
1.37
32.78
1.3
1.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
1167
4046
1.49
32.32
4.6
2.9
mg/l
1.6
1.5
1.37
1079
3682
(3004809) Band form neutrophils/100 leukocytes in Blood
762
2397
1.64
32.09
3.5
3.1
%
1.7
1.5
0.57
576
1837
(3017354) Segmented neutrophils/100 leukocytes in Blood
498
1389
1.85
31.74
3.5
3.0
%
58.5
59.9
0.56
314
856
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
631
1893
1.72
31.65
1.4
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
584
1716
1.76
31.47
1.4
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
1286
4573
1.46
31.39
1.1
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
1796
6780
1.37
31.35
1.2
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
575
1684
1.76
31.33
1.4
1.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
562
1635
1.77
31.31
1.6
1.5
%
59.1
59.9
0.18
358
1073
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
275
615
2.30
31.18
13.1
13.5
nmol/l
806.6
1703.9
0.51
261
590
(3024932) HLA-DR beta [Type]
168
291
2.97
30.97
1.1
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
535
1543
1.79
30.68
4.2
3.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
1412
5134
1.43
30.63
2.4
2.3
g/l
1.0
0.9
0.52
1194
4383
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
1037
3554
1.51
30.36
1.6
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
570
1682
1.75
30.30
1.4
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
567
1674
1.75
30.09
1.4
1.4
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
1500
5539
1.40
29.84
2.3
2.2
ug/l
504.7
649.6
0.78
1414
5191
(3025468) Yersinia sp identified in Specimen by Organism specific culture
565
1672
1.74
29.75
1.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
565
1672
1.74
29.75
1.4
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
1302
4689
1.44
29.75
2.2
2.1
g/l
37.4
37.3
0.12
1095
4001
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
623
1901
1.69
29.45
7.2
5.8
mg/l
11.8
11.6
0.47
566
1731
(3020961) Endomysium IgA Ab [Titer] in Serum
1773
6752
1.36
29.31
1.1
1.1
titre
172.9
222.8
0.43
51
183
(3024471) HLA-A [Type]
170
307
2.85
29.25
1.0
1.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
1246
4470
1.44
29.06
1.8
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
646
2001
1.67
28.90
3.2
3.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
3759
15837
1.24
28.88
4.5
3.5
mmol/l
1.9
1.9
0.04
3045
12813
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
281
657
2.20
28.83
18.7
18.3
nmol/l
1415.9
1376.6
0.34
270
615
(3010421) pH of Blood
1151
4088
1.46
28.30
4.4
3.8
ph
7.4
7.4
0.29
981
3475
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
769
2504
1.59
28.25
1.6
1.3
u/ml
120.8
110.0
0.76
159
522
(3021447) Carbon dioxide [Partial pressure] in Venous blood
3761
15899
1.23
27.97
4.6
3.5
kpa
5.8
5.8
0.08
3643
15384
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
1422
5262
1.40
27.95
1.6
1.6
titre
295.8
292.8
0.01
67
189
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
636
1985
1.65
27.67
1.6
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
930
3190
1.51
27.16
1.7
1.5
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
862
2912
1.53
27.01
1.2
1.2
titre
265.3
96.7
0.64
19
49
(3042111) Morphology [Interpretation] in Bone marrow Narrative
726
2364
1.59
26.70
1.7
1.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
2481
10046
1.28
26.63
8.0
7.2
mmol/l
24.8
24.7
0.56
2461
9948
(3000991) Gas panel - Venous blood
3383
14231
1.24
26.26
8.8
7.8
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
1755
6792
1.34
26.13
1.7
1.5
u/ml
19.6
13.3
0.67
57
178
(4035726)
3379
14223
1.24
26.08
1.4
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
632
2008
1.62
25.70
2.9
2.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
734
2420
1.57
25.63
1.5
1.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
2441
9911
1.28
25.63
4.0
3.2
g/l
128.0
129.3
2.03
2374
9715
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
862
2948
1.51
25.55
3.9
3.4
%
57.6
58.0
0.40
862
2948
(3003181) Sodium [Moles/volume] in Urine
768
2571
1.54
25.10
1.4
1.4
mmol/l
63.7
62.6
0.27
634
2029
(44806118)
511
1545
1.71
25.05
1.6
1.4
—
—
—
0
0
(44790049)
511
1545
1.71
25.05
1.6
1.4
—
—
—
0
0
(44790047)
511
1545
1.71
25.05
1.6
1.4
—
—
—
0
0
(44790048)
511
1545
1.71
25.05
1.6
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
487
1453
1.73
25.02
1.8
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
448
1306
1.77
24.91
1.2
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
1246
4606
1.40
24.67
1.7
1.7
mu/l
299.1
314.1
0.51
1139
4204
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
1216
4478
1.40
24.61
1.6
1.6
g/l
1.2
1.2
0.84
1145
4233
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
2409
9821
1.27
24.47
1.2
1.2
iu/ml
132.4
155.9
1.96
881
3726
(3013290) Carbon dioxide [Partial pressure] in Blood
1001
3568
1.45
24.21
4.4
3.9
kpa
5.0
5.0
0.01
982
3472
(3019832) Treponema pallidum Ab [Presence] in Serum
3141
13220
1.24
24.20
1.7
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
466
1387
1.73
24.17
2.4
2.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
2157
8687
1.29
24.12
3.0
2.6
e6/l
0.3
0.3
1.79
2105
8436
(3027315) Oxygen [Partial pressure] in Blood
1005
3588
1.45
24.10
4.5
3.9
kpa
8.5
8.5
0.36
985
3492
(3012501) Base excess in Blood by calculation
1000
3567
1.45
24.10
4.4
3.9
mmol/l
2.5
2.6
0.38
686
2425
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
1485
5681
1.35
23.86
4.1
2.9
u/ml
0.3
0.3
0.10
866
3166
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
449
1329
1.74
23.75
1.8
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
1090
3963
1.42
23.71
1.5
1.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
453
1348
1.73
23.53
1.4
1.4
mosm/kgh2o
279.8
279.1
0.20
359
1006
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
1105
4036
1.42
23.44
1.3
1.3
miu/ml
224.2
218.1
0.21
490
1851
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
2785
17433
0.81
23.43
1.7
1.8
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
441
1305
1.74
23.35
2.6
2.1
e9/l
1.2
1.2
0.00
275
751
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
1067
3876
1.42
23.33
1.2
1.2
u/ml
41.1
37.5
0.14
66
237
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
2319
9468
1.27
23.26
1.3
1.3
au/ml
53.4
54.0
0.03
80
481
(44816559) Phosphatidylethanol [Mass/volume] in Blood
768
2617
1.51
23.20
1.4
1.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
2513
10364
1.26
23.18
9.1
9.1
%
94.0
93.7
1.13
2503
10327
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
1173
4342
1.40
23.06
1.6
1.6
g/l
0.2
0.2
0.38
1106
4098
(3023511) Choriogonadotropin [Units/volume] in Urine
572
1824
1.62
22.99
1.3
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
444
1324
1.73
22.91
1.5
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
467
1421
1.69
22.44
1.2
1.2
—
—
—
0
0
(3020891) Body temperature
1628
6376
1.32
22.36
4.7
4.9
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
1639
6430
1.32
22.24
1.8
1.9
u/l
38.8
39.0
0.14
1450
5631
(42529406) Shigella sp [Presence] in Stool by Culture
1188
4439
1.38
22.11
1.2
1.2
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
354
997
1.83
22.08
1.7
1.5
u/ml
23.3
25.8
0.46
86
207
(3014765) Yersinia sp identified in Stool by Organism specific culture
1184
4423
1.38
22.07
1.2
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
1144
4251
1.39
22.01
2.3
2.2
g/l
0.0
0.0
1.63
1042
3831
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
357
1010
1.82
21.96
2.3
1.9
%
14.0
13.9
0.04
159
481
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2501
10374
1.25
21.93
9.0
8.9
%
1.4
1.4
0.10
2489
10297
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
1072
3947
1.40
21.76
1.1
1.1
u/ml
6.2
5.3
0.15
106
586
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
994
3611
1.42
21.76
1.3
1.3
u/ml
6.3
8.9
0.82
165
563
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
1128
4190
1.39
21.75
2.3
2.2
g/l
0.0
0.0
0.00
1040
3822
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
2522
10481
1.25
21.75
2.4
2.3
au/ml
21.6
25.0
0.61
102
767
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
2494
10357
1.25
21.65
9.1
9.1
%
0.7
0.7
0.36
2477
10296
(1175426) CD3 cells/100 lymphocytes in Blood
361
1030
1.81
21.62
2.3
1.9
%
72.0
72.1
0.04
345
987
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
1224
4618
1.37
21.49
2.3
2.1
g/l
0.0
0.0
0.08
1118
4180
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
524
1668
1.62
21.25
1.7
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
1171
4395
1.38
21.23
1.2
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
979
3569
1.42
21.03
1.2
1.3
u/ml
5.8
7.6
0.22
102
362
(3023419) Bacteria identified in Sputum by Culture
537
1725
1.60
21.00
2.4
2.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
339
958
1.82
20.95
2.2
1.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
1285
4906
1.35
20.95
3.2
3.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
438
1341
1.68
20.63
1.2
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
328
923
1.83
20.56
1.5
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
3075
13131
1.22
20.53
4.0
3.0
kpa
4.6
4.5
0.87
2971
12630
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
381
1123
1.75
20.52
1.6
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
322
902
1.84
20.47
1.5
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
191
442
2.22
20.26
2.8
2.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
2001
8168
1.27
20.10
4.8
3.7
mmol/l
24.1
24.1
0.02
1820
7266
(3011288) Drugs identified in Urine by Screen method
926
3371
1.42
20.07
3.3
3.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
298
822
1.87
19.88
3.2
3.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
887
3210
1.43
19.86
3.1
3.1
nmol/l
0.8
0.8
0.50
665
2483
(3018405) Lactate [Moles/volume] in Arterial blood
1434
5617
1.32
19.70
3.8
4.1
mmol/l
1.3
1.4
2.29
1410
5525
(3034770) Mitochondria Ab [Titer] in Serum
1085
4079
1.37
19.51
1.2
1.2
titre
1070.6
930.3
0.25
36
111
(3010144) Erythrocytes [#/volume] in Synovial fluid
423
1305
1.67
19.40
1.4
1.4
e6/l
153632.6
112558.4
0.49
289
924
(3009214) Lutropin [Units/volume] in Serum or Plasma
1077
4050
1.37
19.34
1.4
1.4
u/l
9.2
9.6
0.45
880
3283
(3006184) Hemoglobin [Mass/volume] in Capillary blood
965
3563
1.40
19.32
2.3
2.2
g/l
128.5
129.9
0.88
696
2584
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
352
1033
1.75
19.28
1.8
1.7
mg/l
4.3
4.0
0.48
335
983
(1616796) Gas panel - Central venous blood
964
3561
1.40
19.25
3.8
3.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
903
3303
1.41
19.08
3.0
2.5
umol/l
34.9
33.9
0.33
771
2763
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
249
658
1.95
18.86
2.5
2.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
1883
7690
1.27
18.84
3.3
2.8
%
1.3
1.2
0.53
1870
7654
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
815
2938
1.43
18.67
1.2
1.2
u/ml
4.9
5.0
0.01
53
229
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
659
2280
1.49
18.63
1.2
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
701
2458
1.47
18.55
1.2
1.3
u/l
47.1
32.9
1.29
601
2116
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
247
655
1.94
18.54
12.3
10.8
mmol/l
0.6
0.6
0.00
224
602
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
1980
8155
1.26
18.45
2.0
1.9
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
670
2331
1.48
18.44
1.6
1.6
g/l
0.8
0.8
0.25
496
1778
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
661
2300
1.48
18.18
1.5
1.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
1091
4155
1.36
18.12
1.2
1.2
titre
133.8
128.0
0.05
81
352
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
415
1303
1.64
17.86
1.5
1.5
%
29.2
29.2
0.00
250
860
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
386
1189
1.67
17.86
1.8
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
386
1189
1.67
17.86
1.8
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
386
1189
1.67
17.86
1.8
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
1075
4095
1.36
17.84
2.5
2.2
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
177
421
2.16
17.67
1.9
1.5
u/ml
49945.3
22627.2
0.24
28
52
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
87
143
3.13
17.66
5.3
4.1
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
1839
7548
1.26
17.66
3.2
2.8
%
0.7
0.7
1.22
1764
7231
(3020876) Protein [Mass/time] in 24 hour Urine
396
1235
1.65
17.50
2.0
1.8
g/24h
0.9
1.1
0.19
18
82
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
523
1747
1.54
17.43
1.1
1.1
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
134
283
2.43
17.43
1.4
1.3
%
31.8
36.3
0.61
95
186
(3004616) Nuclear Ab [Presence] in Serum
508
1687
1.55
17.38
1.3
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
273
766
1.83
17.36
1.5
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
274
770
1.83
17.34
1.5
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
1845
11692
0.80
17.29
1.4
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
700
2491
1.45
17.22
1.1
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
904
3369
1.38
17.19
2.0
1.8
pmol/l
199.3
202.5
0.34
846
3217
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
288
825
1.80
17.16
1.4
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
293
844
1.79
17.14
1.4
1.2
titre
67.2
77.9
0.17
25
63
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
439
1413
1.60
17.14
1.7
1.7
—
—
—
0
0
(3017704) Immunofixation for Urine
264
738
1.84
17.00
1.6
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
903
3372
1.38
16.97
3.8
3.1
mg/l
25.2
29.0
2.26
535
2332
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
805
2949
1.41
16.92
1.2
1.2
u/ml
12.4
11.3
—
9
37
(3022806) Fractional oxyhemoglobin in Capillary blood
581
2000
1.50
16.88
1.9
1.8
%
89.4
89.5
0.03
570
1972
(3003327) Ova and parasites identified in Stool by Light microscopy
1251
4919
1.31
16.77
1.7
1.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
435
1412
1.59
16.43
3.0
2.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
305
901
1.74
16.43
1.5
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
484
1613
1.55
16.34
1.2
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
1566
6365
1.27
16.32
1.9
1.9
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
276
795
1.79
16.19
1.8
1.9
ug/l
3.2
3.6
0.31
243
688
(3025577) Chromium [Mass/volume] in Blood
269
769
1.80
16.17
1.9
2.0
ug/l
2.1
2.3
0.26
228
649
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
448
1472
1.57
16.09
1.1
1.1
iu/ml
3.3
1.8
—
6
48
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
1051
4057
1.34
16.03
1.9
2.0
mg/l
11.5
11.1
0.41
970
3774
(3010503) CD19 cells [#/volume] in Blood
278
805
1.78
16.03
2.8
2.3
e9/l
0.3
0.3
0.01
270
779
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
296
875
1.74
15.93
1.4
1.2
titre
372.9
473.3
0.20
28
85
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
242
676
1.84
15.67
1.5
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
242
676
1.84
15.67
1.5
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
913
3466
1.36
15.54
2.5
2.5
%
16.1
16.4
1.68
458
1820
(3024928) Oxygen saturation in Venous blood
883
3342
1.36
15.33
4.1
3.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
170
424
2.06
15.17
1.2
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
976
3767
1.34
14.93
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
976
3769
1.34
14.88
1.3
1.3
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
177
452
2.01
14.86
1.2
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
183
474
1.99
14.79
1.8
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
1122
4426
1.31
14.75
2.3
2.3
u/l
6976.1
5354.9
0.74
444
1888
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
1387
5626
1.27
14.73
1.7
1.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
192
508
1.94
14.63
2.3
1.9
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
393
1283
1.58
14.56
2.4
2.1
%
41.2
41.5
0.04
39
152
(3016879) Cocaine [Presence] in Urine
1263
5075
1.29
14.46
2.5
2.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
433
1449
1.54
14.42
1.1
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
3886
17443
1.16
14.42
4.0
4.1
ug/l
24.8
29.8
0.39
3130
14136
(3038026) Centromere Ab [Units/volume] in Serum
340
1074
1.63
14.41
1.2
1.2
u/ml
53.8
54.3
0.01
12
54
(3023323) Follitropin [Units/volume] in Serum or Plasma
1532
6310
1.25
14.33
1.3
1.3
iu/l
28.5
29.0
0.21
1304
5436
(3043409) Potassium [Moles/volume] in Arterial blood
1212
4851
1.29
14.31
4.0
4.4
mmol/l
3.9
3.9
0.45
1138
4563
(3016650) Hepatitis A virus Ab [Presence] in Serum
677
2483
1.41
14.22
1.1
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
321
1003
1.65
14.20
1.6
1.5
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
339
1075
1.62
14.16
2.1
2.1
nmol/l
17.7
16.8
0.92
315
1025
(3020717) Zinc [Moles/volume] in Serum or Plasma
225
636
1.82
14.10
1.5
1.5
umol/l
20.2
29.0
4.12
212
606
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
309
958
1.66
14.08
1.2
1.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
1924
8145
1.22
13.99
3.9
3.3
mmol/l
25.3
25.2
0.31
1854
7911
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
2100
8971
1.21
13.94
9.4
9.1
mmol/l
24.3
24.3
0.17
1963
8290
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
733
2735
1.38
13.94
3.8
2.6
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
430
1450
1.53
13.86
1.4
1.3
g/l
3.0
3.0
0.08
298
1014
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
679
2507
1.40
13.75
1.2
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
1347
5492
1.27
13.74
2.4
2.0
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
429
1449
1.52
13.73
1.4
1.3
g/l
0.4
0.4
0.84
294
1015
(3028300) Cannabinoids [Presence] in Urine
1360
5552
1.27
13.73
2.4
2.0
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
693
2569
1.39
13.71
2.0
1.8
mmol/l
1.7
1.8
1.35
677
2503
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
531
1876
1.46
13.68
1.3
1.2
mmol/l
7.4
7.4
0.05
381
1433
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
242
707
1.76
13.64
2.1
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
242
707
1.76
13.64
2.1
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
242
707
1.76
13.64
2.1
1.5
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
304
948
1.65
13.58
2.6
2.2
e6/l
511.8
521.6
0.09
248
771
(3027135) IgG subclass 1 [Mass/volume] in Serum
429
1453
1.52
13.57
1.4
1.3
g/l
6.9
6.7
0.51
293
1017
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
762
2877
1.37
13.49
1.2
1.2
u/ml
46.5
40.2
0.44
85
272
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
241
706
1.76
13.47
2.1
1.5
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
329
1052
1.61
13.33
1.2
1.2
u/ml
47.9
41.4
0.18
25
90
(3027008) Opiates [Presence] in Urine
1353
5541
1.26
13.31
2.2
2.0
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
38
41
4.76
13.19
11.8
11.6
e6/l
210.0
197.5
0.06
27
31
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
327
1049
1.60
13.09
1.1
1.2
u/ml
86.6
70.3
0.37
15
45
(21494890) Protein electrophoresis panel - 24 hour Urine
453
1569
1.49
12.92
2.1
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
912
3563
1.32
12.91
1.6
1.5
—
—
—
0
0
(4211845)
228
666
1.76
12.89
3.8
3.0
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
292
915
1.64
12.83
2.6
2.2
e9/l
0.2
0.2
2.85
243
769
(3029634) Reagin Ab [Titer] in Serum by VDRL
552
1990
1.43
12.82
2.2
2.2
titre
2.5
9.0
1.72
17
71
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
90
184
2.51
12.64
9.4
6.8
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
1053
4211
1.29
12.57
3.3
3.1
mmol/l
24.6
24.8
1.13
917
3715
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
958
3785
1.31
12.52
1.4
1.3
mg/l
502.9
560.6
1.75
901
3612
(3024263) Appearance of Synovial fluid
240
718
1.72
12.52
1.8
1.6
—
—
—
0
0
(4062490)
426
1467
1.49
12.51
1.4
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
196
552
1.83
12.49
2.3
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
194
545
1.83
12.46
2.3
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
194
545
1.83
12.46
2.3
1.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
1214
4948
1.27
12.46
1.8
1.7
nmol/l
40.6
41.3
0.51
1171
4844
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
311
1000
1.60
12.36
1.1
1.2
u/ml
3.5
6.6
0.63
16
75
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
506
1811
1.44
12.24
1.4
1.3
u/l
27.5
28.0
0.10
414
1511
(3051593) INR in Capillary blood by Coagulation assay
242
731
1.70
12.22
10.0
11.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
990
3944
1.29
12.18
1.1
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
1322
5461
1.25
12.11
2.4
1.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
1205
4928
1.26
12.03
1.4
1.3
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
256
791
1.66
11.91
2.6
2.7
%
39.7
39.0
0.16
93
220
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
850
3333
1.31
11.77
1.4
1.3
mmol/l
3.8
3.7
0.25
792
3113
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
156
416
1.93
11.74
2.3
1.9
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
372
1265
1.51
11.63
1.1
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
502
1818
1.42
11.43
1.6
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
230
699
1.69
11.40
4.1
3.6
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
19
10
9.75
11.35
3.9
3.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
136
350
2.00
11.32
1.4
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
528
1935
1.41
11.26
1.1
1.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
1105
4512
1.26
11.21
1.4
1.4
iu/ml
16.0
9.7
0.65
25
99
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
443
1574
1.45
11.19
1.2
1.2
u/l
69.0
62.9
0.30
304
1057
(3000034) Microalbumin [Mass/volume] in Urine
398
1390
1.47
10.98
2.9
3.0
mg/l
34.4
63.3
2.00
299
1008
(3028433) Virus identified in Specimen by Culture
159
439
1.86
10.85
1.1
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
115
283
2.09
10.78
1.1
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
368
1270
1.49
10.78
1.2
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
208
625
1.71
10.77
4.0
3.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
3185
18484
0.88
10.64
1.4
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
897
3597
1.29
10.56
1.8
1.9
iu/l
4.6
15.3
1.20
312
1331
(3035320) C reactive protein [Mass/volume] in Body fluid
302
1006
1.54
10.43
2.5
2.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
508
1878
1.39
10.35
2.9
2.5
%
13.1
13.2
0.48
502
1840
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
178
518
1.77
10.31
2.1
1.9
%
28.8
28.3
0.15
165
492
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
1766
7648
1.19
10.20
4.6
3.9
%
48.6
47.8
0.70
1746
7558
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
155
434
1.84
10.17
2.1
1.8
ug/l
58.6
56.5
0.09
150
425
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
162
461
1.81
10.10
2.4
2.4
nmol/l
148.6
148.5
0.00
142
392
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
557
2100
1.37
10.09
1.3
1.3
nmol/l
0.2
0.3
0.37
30
158
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
203
619
1.69
10.01
1.2
1.1
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
178
523
1.75
10.00
2.2
1.9
%
11.2
11.2
0.01
163
488
(3034891) Synovial lining cells/100 cells in Synovial fluid
210
648
1.67
9.92
1.5
1.4
%
4.1
3.4
0.21
46
167
(3045142) Bone marrow Pathology biopsy report
449
1640
1.41
9.83
1.4
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
227
717
1.63
9.81
1.3
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
819
3279
1.29
9.80
1.2
1.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
555
2103
1.36
9.76
1.3
1.3
nmol/l
0.6
1.3
0.68
531
2030
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
839
3372
1.28
9.75
1.6
1.5
e6/l
1485.8
1663.0
0.09
684
2708
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
255
831
1.58
9.72
1.5
1.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
838
3370
1.28
9.69
1.5
1.4
e6/l
20.6
27.9
0.56
644
2589
(3045716) Anion gap in Serum or Plasma
210
653
1.65
9.65
2.3
2.3
mmol/l
9.4
9.4
0.00
165
487
(3027923) C peptide [Moles/volume] in Serum or Plasma
238
766
1.60
9.56
1.4
1.5
nmol/l
1.2
1.2
0.02
180
593
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
121
319
1.95
9.51
4.8
6.0
%
70.2
72.3
0.34
88
245
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
1026
4246
1.25
9.35
1.4
1.3
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
245
799
1.58
9.33
1.5
1.4
u/l
6.1
6.5
0.24
215
649
(3020191) Ethanol [Moles/volume] in Serum or Plasma
339
1187
1.47
9.32
1.6
1.4
promille
1.3
1.4
0.63
260
916
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
656
2569
1.32
9.28
1.5
1.5
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
190
582
1.68
9.26
1.6
1.4
iu/ml
1614050.0
2098009.4
0.26
13
42
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
180
544
1.70
9.21
1.1
1.1
u/ml
4.3
10.1
1.69
31
99
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
368
1313
1.44
9.20
1.3
1.3
nmol/l
1.5
1.4
0.56
330
1189
(3038071) Oxygen [Partial pressure] in Mixed venous blood
110
284
1.99
9.18
8.8
8.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
81
185
2.25
9.15
1.5
1.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
283
959
1.52
9.12
1.3
1.2
mmol/l
33.5
35.6
0.82
239
830
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
487
1830
1.37
9.07
1.3
1.3
nmol/l
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
132
365
1.86
9.06
1.3
1.2
nmol/l
120.0
136.5
0.52
97
264
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
241
792
1.56
8.91
1.8
1.7
u/field
2.0
2.7
0.83
172
577
(44813793)
278
944
1.51
8.89
1.1
1.1
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
101
256
2.03
8.87
2.0
2.6
mmol/l
7.2
7.8
0.77
68
157
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
216
694
1.60
8.78
6.2
6.2
u/ml
90.3
6210.7
0.81
46
150
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
4967
23315
1.11
8.77
1.5
1.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
229
747
1.58
8.75
1.3
1.3
mmol/l
5.9
5.8
0.69
214
721
(3020491) Glucose [Moles/volume] in Blood
311
1086
1.47
8.71
1.8
1.9
mmol/l
6.7
6.9
0.26
216
784
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
245
813
1.55
8.70
1.1
1.1
nmol/l
7.2
6.7
0.07
48
175
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
122
334
1.88
8.65
8.3
8.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
302
1052
1.48
8.57
2.6
2.3
e6/l
623.3
697.1
0.89
121
396
(3012565) Volume of 24 hour Urine
222
723
1.58
8.55
2.6
2.0
ml
1910.0
1973.1
0.38
195
635
(3032057) Clostridioides difficile [Presence] in Stool
113
305
1.90
8.37
1.8
1.9
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
54
106
2.62
8.35
1.1
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
456
1721
1.36
8.31
1.1
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
500
1915
1.34
8.29
1.3
1.3
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
530
2048
1.33
8.29
1.1
1.1
g/l
1.5
1.5
0.21
473
1845
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
918
3807
1.24
8.27
1.3
1.2
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
163
495
1.69
8.26
8.3
6.0
mmol/l
24.8
24.8
0.01
152
439
(3047189) Immunofixation for 24 hour Urine
216
706
1.57
8.22
1.8
1.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
128
363
1.81
8.17
1.1
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
131
376
1.79
8.06
1.2
1.2
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
21
21
5.13
7.93
3.2
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
702
2840
1.27
7.84
1.7
1.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
136
399
1.75
7.80
2.0
1.7
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
240
815
1.51
7.75
1.1
1.2
ratio
1.1
1.1
1.34
86
271
(4306422)
588
2333
1.30
7.66
1.2
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
152
463
1.69
7.65
1.5
1.3
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
568
2244
1.30
7.64
1.1
1.1
%
116.2
118.2
0.68
512
2023
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
410
1544
1.37
7.62
3.6
3.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
587
2335
1.29
7.51
1.1
1.1
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
142
427
1.71
7.50
1.3
1.3
%
56.3
57.2
0.09
121
369
(3019977) pH of Arterial blood
243
835
1.50
7.44
2.5
2.2
ph
7.4
7.4
0.72
90
320
(3006922) Hepatitis E virus Ab [Presence] in Serum
294
1052
1.44
7.35
1.1
1.1
—
—
—
0
0
(4015189)
121
350
1.78
7.30
2.3
2.0
—
—
—
0
0
(4094501)
1034
4403
1.21
7.28
1.1
1.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
790
3273
1.24
7.24
3.5
3.3
u/ml
664.3
1034.3
0.43
726
2968
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
20
21
4.89
7.22
3.0
1.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
966
4093
1.22
7.16
4.7
3.8
kpa
8.2
8.1
0.50
890
3820
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
147
453
1.67
7.13
1.0
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
261
920
1.46
7.08
1.6
1.6
u/l
6.4
6.6
0.05
123
459
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
273
972
1.44
7.03
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
272
968
1.44
7.02
1.0
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
309
1126
1.41
7.02
1.3
1.2
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
150
467
1.65
7.01
1.2
1.2
g/l
0.3
0.3
2.05
115
380
(3048879) Bone marrow aspiration report
134
405
1.70
6.99
1.9
1.5
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
465
1812
1.32
6.95
1.2
1.2
u/ml
51.8
49.0
0.07
30
111
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
84
219
1.97
6.94
2.2
2.0
umol/l
16.7
16.8
0.02
84
219
(1002224) Polysomnography panel
1523
6748
1.16
6.81
1.1
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
71
175
2.08
6.81
1.5
1.1
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
153
484
1.62
6.75
1.6
1.3
pmol/l
16.7
15.1
0.73
126
414
(3044290) Cell count panel - Cerebral spinal fluid
758
3153
1.24
6.74
1.5
1.4
—
—
—
0
0
(4198724)
178
585
1.56
6.72
3.0
2.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
137
422
1.67
6.69
2.3
2.5
au/ml
154.8
150.0
0.03
22
51
(3036489) Thrombin time
1410
6221
1.17
6.66
2.6
2.0
s
21.6
21.7
0.30
1219
5516
(3040151) Glucose [Moles/volume] in Capillary blood
477
1879
1.31
6.62
20.4
8.3
mmol/l
7.2
7.5
0.87
393
1545
(3009015) Lactate [Moles/volume] in Synovial fluid
54
120
2.31
6.60
1.2
1.2
mmol/l
4.9
6.5
1.44
21
68
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
200
678
1.52
6.59
1.4
1.2
%
69.0
63.2
0.38
27
76
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
948
4045
1.21
6.58
2.4
2.3
ug/min
135.1
94.0
1.51
566
2457
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
403
1552
1.34
6.56
1.4
1.3
u/l
301.5
470.7
2.40
382
1463
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
183
609
1.54
6.55
2.3
1.6
umol/l
117.0
114.2
0.05
88
320
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
1106
4798
1.19
6.42
3.4
2.4
g/l
3.5
3.6
2.20
1051
4571
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
146
463
1.62
6.40
2.9
3.0
mg/l
7.5
7.8
0.20
118
379
(3003434) Protein [Mass/volume] in Pleural fluid
583
2371
1.27
6.34
1.5
1.4
g/l
31.2
33.1
2.86
515
2101
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
269
976
1.42
6.31
1.0
1.0
ng/l
45.5
39.7
1.09
175
667
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
82
220
1.91
6.30
3.7
2.6
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
214
745
1.48
6.24
2.3
2.1
ug/min
135.9
113.2
0.17
56
164
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
186
630
1.52
6.18
2.3
2.4
umol/l
55.6
55.5
0.01
151
526
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
442
1742
1.31
6.15
2.0
1.8
titre
1260.8
4297.1
2.18
25
91
(3002619) Bacteria identified in Specimen by Culture
95
270
1.81
6.15
1.3
1.3
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
226
798
1.46
6.14
1.6
1.5
mmol/l
8.2
7.8
0.99
140
489
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
302
1124
1.38
6.14
1.3
1.3
mmol/l
2.0
2.2
3.18
286
1041
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
32
56
2.93
6.13
3.2
2.8
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
136
429
1.63
6.11
1.2
1.2
%
108.9
113.4
1.07
120
377
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
305
1138
1.38
6.11
1.0
1.1
mg/l
285.7
291.9
0.70
273
1021
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
179
603
1.53
6.11
1.0
1.1
%
95.7
97.3
0.25
141
462
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
114
343
1.71
6.10
1.6
1.5
ug/l
8.6
8.9
0.34
114
343
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
267
974
1.41
6.10
1.0
1.0
ng/l
734.5
726.1
0.10
173
650
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
175
587
1.53
6.09
1.3
1.2
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
266
971
1.41
6.06
1.0
1.0
ng/l
317.7
315.1
0.05
176
675
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
107
317
1.73
6.05
1.5
1.5
ug/l
0.4
0.4
0.29
65
202
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
78
209
1.92
6.03
1.5
1.6
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
212
743
1.47
6.00
1.1
1.1
u/l
90.4
88.0
0.11
166
594
(3003129) Base excess in Capillary blood by calculation
117
357
1.68
5.97
1.8
1.8
mmol/l
0.5
0.8
0.27
109
335
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
592
2433
1.25
5.92
1.2
1.3
u/ml
3.4
4.5
0.66
182
838
(3025018) Bordetella pertussis Ab [Titer] in Serum
230
822
1.44
5.89
1.3
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
612
3869
0.81
5.85
1.5
1.7
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
184
630
1.50
5.85
1.1
1.2
u/ml
29.3
11.0
0.41
16
62
(3035947) Staphylolysin Ab [Units/volume] in Serum
220
781
1.45
5.84
1.1
1.1
iu/ml
3.3
4.0
0.37
12
64
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
211
743
1.46
5.84
1.1
1.1
u/l
27.2
27.4
0.01
159
579
(3016244) Insulin [Units/volume] in Serum or Plasma
230
824
1.43
5.82
3.3
3.3
mu/l
26.4
26.3
0.01
218
774
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
1169
5142
1.17
5.80
3.7
2.2
%
91.4
91.1
0.15
1089
4818
(4146454)
432
1713
1.30
5.78
2.8
2.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
131
417
1.61
5.71
3.2
2.6
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
25
39
3.29
5.71
1.2
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
687
2883
1.23
5.70
1.1
1.1
u/ml
1.3
1.6
0.47
282
1161
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
13
11
6.07
5.68
6.1
3.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
97
285
1.75
5.67
1.1
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
301
1137
1.36
5.63
1.2
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
203
716
1.46
5.60
1.1
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
118
368
1.65
5.58
1.2
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
128
1019
0.64
5.57
1.3
1.3
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
318
1215
1.35
5.54
1.5
1.4
u/l
12.7
13.2
0.63
304
1171
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
344
1330
1.33
5.54
1.2
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
241
881
1.41
5.49
1.5
1.6
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
207
737
1.44
5.45
2.0
2.0
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
149
496
1.54
5.42
2.5
2.4
ug/l
1.2
1.2
0.01
140
471
(3036525) Urea [Moles/time] in 24 hour Urine
34
67
2.61
5.35
3.4
2.6
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
242
891
1.40
5.31
1.2
1.2
u/l
31.3
24.9
0.80
203
765
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
342
1330
1.32
5.31
1.9
2.1
u/field
1.8
2.4
0.84
155
499
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
249
922
1.39
5.29
1.2
1.2
u/l
111.3
93.0
1.21
213
804
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
271
1018
1.37
5.28
3.0
3.4
nmol/l
128.2
145.1
0.31
266
1004
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
138
455
1.56
5.25
1.3
1.3
ug/l
538.1
165.9
0.76
70
250
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
524
2157
1.25
5.23
1.1
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
454
1838
1.27
5.22
1.7
1.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
181
634
1.47
5.20
2.5
2.3
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
125
404
1.59
5.17
2.1
1.8
e6/l
238.4
1305.0
1.08
61
215
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
317
1225
1.33
5.16
1.3
1.3
u/l
14.2
13.0
0.32
289
1134
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
243
901
1.39
5.14
1.2
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
498
2043
1.25
5.13
1.5
1.4
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
128
418
1.57
5.08
1.3
1.2
g/l
39.3
40.3
0.32
68
244
(3001186) Copper [Moles/volume] in Serum or Plasma
109
342
1.64
5.08
1.3
1.3
umol/l
17.4
16.7
0.45
94
308
(40763480) Human metapneumovirus Ag [Presence] in Specimen
28
51
2.82
5.07
1.1
1.3
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
79
227
1.79
5.02
3.2
2.6
u/l
1821.7
1682.8
0.05
72
203
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
285
1089
1.35
5.01
1.2
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
130
428
1.56
5.00
1.8
1.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
164
569
1.48
4.97
1.1
1.1
miu/ml
1488.4
1554.0
0.30
164
569
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
571
2388
1.23
4.96
1.3
1.3
u/ml
4.4
4.1
0.15
241
1061
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
240
894
1.38
4.95
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
284
1087
1.34
4.95
1.2
1.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
32
64
2.57
4.92
3.7
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
284
1089
1.34
4.89
1.2
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
370
1473
1.29
4.89
1.4
1.3
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
60
159
1.94
4.87
2.1
2.1
—
—
—
0
0
(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid
23
38
3.11
4.87
4.9
5.4
mmol/l
16.4
17.9
0.41
18
33
(3011985) Renin [Units/volume] in Plasma
513
2126
1.24
4.86
1.5
1.5
mu/l
58.1
71.9
0.70
447
1902
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
286
1100
1.34
4.83
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
286
1100
1.34
4.83
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
286
1101
1.34
4.81
1.2
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
205
748
1.41
4.79
1.8
1.9
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
92
281
1.68
4.77
1.4
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
737
3174
1.19
4.77
2.9
2.8
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
243
915
1.36
4.72
1.1
1.1
iu/ml
12.1
8.9
0.73
48
260
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
412
1671
1.27
4.72
1.1
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
449
1840
1.25
4.71
1.6
1.5
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
228
850
1.38
4.71
2.7
2.3
umol/l
43.7
57.0
0.46
30
105
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
585
2468
1.22
4.70
1.7
1.8
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
258
982
1.35
4.68
1.3
1.3
u/ml
1.0
1.6
0.56
114
436
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
215
795
1.39
4.66
1.4
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
215
795
1.39
4.66
1.4
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
815
3550
1.18
4.65
1.2
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
153
533
1.47
4.58
1.3
1.2
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
182
657
1.42
4.54
6.0
3.4
mg/l
63.8
2740.1
2.59
132
453
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
132
447
1.52
4.52
1.3
1.2
%
27.7
20.2
0.38
15
75
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
23
40
2.95
4.52
2.2
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
143
493
1.49
4.51
1.2
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
166
590
1.45
4.50
3.4
1.8
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
15
19
4.05
4.49
9.3
4.6
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
396
1609
1.27
4.49
1.5
1.5
iu/ml
23.5
32.0
0.97
22
68
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
473
1962
1.24
4.48
1.4
1.3
pmol/l
278.4
302.6
0.54
366
1484
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
361
1452
1.28
4.45
1.4
1.6
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
96
303
1.63
4.43
1.5
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
127
429
1.52
4.41
2.7
2.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
127
429
1.52
4.41
2.7
2.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
193
709
1.40
4.38
1.2
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
83
253
1.68
4.37
2.3
1.7
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
112
369
1.56
4.35
1.1
1.1
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
152
536
1.46
4.31
1.2
1.2
g/l
0.1
0.3
1.06
11
32
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
72
212
1.74
4.28
1.7
1.6
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
63
178
1.82
4.28
1.9
1.8
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
62
175
1.82
4.23
2.1
2.0
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
422
1741
1.25
4.23
1.1
1.1
%
96.2
96.2
0.00
395
1629
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
110
364
1.55
4.21
1.1
1.1
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
202
755
1.37
4.16
1.4
1.5
ug/l
8.4
7.4
0.38
174
695
(3001019) Free T4 and TSH panel - Serum or Plasma
1607
9164
0.90
4.15
1.7
1.7
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
111
370
1.54
4.12
1.1
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
43
108
2.04
4.09
1.8
2.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
36
84
2.20
4.08
1.1
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
28
58
2.48
4.08
5.3
4.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
246
952
1.33
4.07
1.2
1.1
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
97
315
1.58
4.04
1.7
1.7
au/ml
74.4
130.9
—
9
37
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
108
360
1.54
4.02
1.1
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
280
1106
1.30
4.01
1.7
1.7
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
112
377
1.53
4.00
1.1
1.1
u/ml
5.4
9.9
1.05
16
54
(4268621)
393
1625
1.24
3.90
2.3
2.4
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
320
1293
1.27
3.86
1.3
1.3
mmol/l
12.1
12.1
0.02
84
374
(3010838) Calcium [Moles/time] in 24 hour Urine
193
728
1.36
3.80
1.6
1.6
mmol/24h
6.5
5.9
0.29
15
61
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
210
803
1.34
3.79
3.3
1.9
%
94.4
99.1
1.19
200
759
(3035611) Eosinophils/100 leukocytes in Synovial fluid
38
94
2.08
3.78
1.6
1.6
%
1.3
0.5
0.82
28
76
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
126
441
1.47
3.77
1.1
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
389
1614
1.24
3.76
2.3
2.1
umol/l
9.6
7.5
0.57
281
1180
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
1050
4745
1.14
3.76
3.0
2.3
%
188.2
192.3
0.76
996
4502
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
49
134
1.88
3.72
1.2
1.2
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
34
81
2.15
3.70
1.3
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
94
310
1.56
3.70
1.6
1.5
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
93
306
1.56
3.70
1.2
1.2
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
42
109
1.98
3.70
1.2
1.3
ml/s/173m2
1.0
1.2
0.44
31
65
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
102
343
1.53
3.69
1.3
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
381
1581
1.24
3.69
1.2
1.2
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
33
78
2.17
3.67
1.1
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
68
207
1.69
3.66
1.1
1.1
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
139
499
1.43
3.66
1.4
1.3
mmol/l
3.7
3.5
0.26
123
460
(3023199) Leukocytes [#/volume] in Pleural fluid
505
2159
1.20
3.65
1.6
1.5
e6/l
2499.1
2831.2
0.24
365
1553
(3016018) Differential panel - Cerebral spinal fluid
409
1714
1.23
3.62
1.5
1.5
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
173
648
1.37
3.58
1.6
1.6
nmol/l
5.7
7.7
0.21
142
540
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
378
1573
1.24
3.58
1.1
1.1
au/ml
55.7
61.9
—
5
16
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
120
421
1.46
3.57
2.2
1.9
mg/l
9.6
9.2
0.27
96
349
(3036782) Glucose [Moles/volume] in Pleural fluid
390
1629
1.23
3.57
1.4
1.3
mmol/l
6.2
6.4
0.70
360
1492
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
199
764
1.34
3.53
3.6
3.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
49
137
1.84
3.51
1.2
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
528
2277
1.19
3.49
3.1
2.6
u/ml
747.9
793.1
0.03
513
2181
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
389
1629
1.23
3.48
1.1
1.1
au/ml
3.4
2.1
—
6
5
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
316
1294
1.25
3.46
1.2
1.2
titre
105.7
162.1
0.57
14
38
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
89
295
1.55
3.46
1.4
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
181
688
1.35
3.44
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
504
2168
1.20
3.44
1.2
1.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
167
627
1.37
3.43
1.9
1.9
umol/l
29.5
29.1
0.17
158
600
(3028679) Herpes simplex virus Ab [Presence] in Serum
205
795
1.32
3.42
1.2
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
316
1297
1.25
3.40
1.2
1.2
titre
168.9
192.4
0.20
55
218
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
64
196
1.68
3.40
1.1
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
101
346
1.50
3.39
1.1
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
226
890
1.30
3.38
1.2
1.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
49
139
1.81
3.37
1.1
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
60
181
1.70
3.37
1.1
1.1
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
46
128
1.84
3.36
1.8
1.7
mg/l
1.4
1.8
0.87
38
113
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
107
373
1.47
3.31
1.5
1.4
%
24.2
22.1
0.33
90
298
(3010726) Horse dander IgE Ab [Units/volume] in Serum
563
2455
1.18
3.30
1.1
1.1
u/ml
1.5
2.0
0.85
130
588
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
1152
6597
0.89
3.29
1.8
1.6
mg/l
4.4
3.1
1.50
829
4533
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
46
129
1.83
3.29
1.1
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
35
89
2.02
3.29
1.0
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
459
1967
1.20
3.28
1.5
1.4
e6/l
64394.4
53397.2
0.27
274
1186
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
38
100
1.95
3.26
1.1
1.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
609
2677
1.17
3.25
1.1
1.1
u/ml
4.7
4.7
0.03
315
1339
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
1270
5864
1.11
3.24
1.9
1.7
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
558
2438
1.18
3.21
1.1
1.1
au/ml
13.5
11.1
0.18
28
182
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
101
351
1.48
3.19
1.1
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
575
2520
1.17
3.19
1.1
1.1
iu/ml
97.2
5315.9
0.60
141
486
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
69
220
1.61
3.18
1.1
1.3
ng/l
1278.5
159.3
0.44
44
151
(3007542) Rye IgE Ab [Units/volume] in Serum
25
56
2.29
3.16
1.0
1.0
u/ml
1.4
0.1
—
10
25
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
43
120
1.84
3.13
1.1
1.0
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
85
286
1.53
3.13
1.1
1.1
umol/24h
0.7
0.7
0.14
36
140
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
51
151
1.73
3.08
2.8
2.6
u/field
0.6
0.5
0.27
51
151
(3042517) Benzodiazepines panel - Urine
42
117
1.84
3.08
2.5
3.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
43
121
1.82
3.06
1.1
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
86
292
1.51
3.05
1.8
2.5
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
433
1860
1.20
3.05
3.0
3.2
nmol/l
18.6
6.5
0.46
419
1810
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
85
288
1.52
3.04
3.0
5.6
u/l
93.7
52.4
0.38
25
120
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
109
389
1.44
3.03
1.2
1.2
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
68
219
1.59
3.03
3.0
1.7
mmol/l
2.3
2.6
0.51
63
196
(3024891) Influenza virus A+B Ag [Presence] in Specimen
1041
4774
1.12
3.02
1.2
1.1
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
163
624
1.34
3.01
1.5
1.4
%
64.9
62.9
0.33
137
501
(3013005) Retinol [Moles/volume] in Serum or Plasma
162
620
1.34
3.00
2.0
1.9
umol/l
1.9
2.0
0.03
155
576
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
115
416
1.42
2.98
2.1
2.1
u/l
24.7
46.7
1.77
106
384
(40762365) Oxygen content in Arterial blood by calculation
79
265
1.53
2.97
2.8
3.0
ml/dl
14.9
14.5
0.50
72
248
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
170
658
1.33
2.93
1.1
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
59
185
1.64
2.93
1.0
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
3229
15603
1.07
2.88
1.4
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
388
1660
1.20
2.88
1.6
1.5
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
85
292
1.49
2.88
1.4
1.3
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
57
178
1.64
2.88
9.8
8.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
64
206
1.60
2.87
2.1
2.3
ug/l
4.4
4.0
0.15
27
63
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
14
24
2.99
2.87
1.2
1.1
%
3.2
2.2
0.36
14
24
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
15
27
2.85
2.85
1.5
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
44
128
1.76
2.85
1.2
1.2
—
—
—
0
0
(4212803)
47
141
1.71
2.75
1.1
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
78
266
1.51
2.75
3.8
1.7
mmol/l
1.2
1.2
1.31
78
255
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
25
60
2.14
2.75
1.0
1.0
u/ml
0.1
0.1
0.10
14
20
(3008401) Mugwort IgE Ab [Units/volume] in Serum
579
2574
1.16
2.74
1.1
1.1
u/ml
1.3
1.1
0.31
260
1048
(3006442) Creatine [Moles/volume] in Serum or Plasma
276
1148
1.24
2.73
1.5
1.6
umol/l
65.5
74.1
1.20
16
104
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
1323
6186
1.10
2.71
3.5
3.5
u/ml
1942.7
1654.1
0.11
1116
5339
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
14
25
2.87
2.71
1.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
40
115
1.79
2.70
1.6
1.5
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
41
119
1.77
2.69
1.1
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
41
119
1.77
2.69
5.0
4.7
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
168
659
1.31
2.68
1.4
1.3
umol/l
4.3
4.7
0.65
158
604
(37021550) Renin [Units/volume] in Plasma --upright
84
294
1.47
2.63
1.3
1.3
mu/l
80.2
68.7
0.25
59
221
(3014133) Dog dander IgE Ab [Units/volume] in Serum
484
2131
1.17
2.61
1.0
1.1
u/ml
3.4
5.1
1.36
183
817
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
11
4.20
2.61
6.9
1.0
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
37
105
1.81
2.61
1.4
1.1
nmol/l
14.6
14.8
0.03
12
28
(3018001) Oat IgE Ab [Units/volume] in Serum
31
83
1.92
2.60
1.1
1.0
u/ml
0.3
0.3
0.10
11
31
(3035880) pH of Pleural fluid
231
949
1.25
2.58
1.3
1.3
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
74
254
1.50
2.56
1.4
1.4
%
8.5
11.5
0.70
37
127
(40768441) Liver Pathology biopsy report
278
1168
1.22
2.53
1.5
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
162
638
1.30
2.53
2.2
1.5
%
151.9
144.6
0.47
152
600
(3041918) Cholesterol [Moles/volume] in Pleural fluid
80
282
1.46
2.45
1.2
1.2
mmol/l
1.7
1.6
0.21
46
178
(40758292) HTLV I+II Ab panel - Serum
67
228
1.51
2.43
1.4
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
126
482
1.34
2.42
1.1
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
202
1291
0.80
2.40
1.3
1.3
g/l
1.5
1.5
0.02
17
58
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
40
120
1.71
2.39
10.7
6.8
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
62
209
1.52
2.35
1.7
1.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
89
323
1.41
2.35
1.1
1.1
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
26
68
1.96
2.34
1.0
1.0
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
20
47
2.18
2.34
1.1
1.1
u/ml
1.1
0.6
—
10
24
(3001893) Eosinophils/100 leukocytes in Pleural fluid
136
530
1.32
2.32
1.5
1.4
%
2.1
2.6
0.42
116
438
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
48
153
1.61
2.31
1.0
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
328
1416
1.19
2.29
4.7
5.0
u/ml
64.4
114.3
1.05
100
435
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
10
16
3.21
2.28
1.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
10
16
3.21
2.28
2.0
1.9
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
10
16
3.21
2.28
2.0
2.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
10
16
3.21
2.28
2.0
1.9
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
10
16
3.21
2.28
1.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
10
16
3.21
2.28
1.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
56
186
1.55
2.28
1.3
1.1
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
18
41
2.25
2.26
7.8
4.2
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
209
864
1.24
2.26
1.2
1.2
u/l
330.5
345.2
0.06
182
831
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
276
1175
1.21
2.25
1.4
1.4
umol/l
12.9
12.2
0.73
261
1112
(3037297) Penicillin G IgE Ab [Units/volume] in Serum
22
55
2.05
2.24
1.0
1.0
u/ml
0.0
0.1
0.14
12
15
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
75
267
1.44
2.21
1.4
1.2
mg/l
26.8
63.3
0.42
58
192
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
51
167
1.57
2.21
1.6
1.6
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
8
11
3.73
2.16
1.5
1.4
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
48
156
1.58
2.16
1.1
1.1
—
—
—
0
0
(3007147) Virus identified in Stool by Electron microscopy
6
6
5.13
2.15
1.0
1.0
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
62
214
1.49
2.14
1.4
1.3
nmol/l
161233.7
302267.9
0.30
49
177
(3051611) Lipemic interference index of Serum or Plasma
408
1806
1.16
2.13
3.0
3.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
330
1437
1.18
2.12
1.0
1.1
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
121
472
1.32
2.09
1.5
1.4
%
19.9
20.6
0.10
111
421
(3020650) Glucose [Presence] in Urine
105
401
1.34
2.09
1.4
1.4
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
135
535
1.30
2.08
2.5
3.0
umol/l
27.7
29.4
0.94
98
406
(3033086) Enterovirus NOS Ab [Titer] in Serum
16
36
2.28
2.07
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
88
327
1.38
2.07
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
88
327
1.38
2.07
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
88
327
1.38
2.07
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
88
327
1.38
2.07
1.1
1.1
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
37
114
1.67
2.05
1.3
1.6
mg/l
1.6
1.9
0.14
22
74
(3013336) Amino acids [Identifier] in Serum or Plasma
20
50
2.05
2.05
3.6
1.8
—
—
—
0
0
(21494227) Amikacin free [Mass/volume] in Serum or Plasma
15
33
2.33
2.04
4.5
4.5
mg/l
3.5
5.3
—
10
25
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
182
751
1.24
2.04
1.8
2.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
270
1160
1.20
2.03
1.1
1.1
mg/l
256.1
290.3
1.63
233
1031
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
124
488
1.30
2.02
2.3
1.5
%
169.9
173.1
0.12
117
464
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
648
3713
0.89
2.02
1.4
1.4
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
56
192
1.50
2.02
1.3
1.3
u/l
649.4
61.3
0.53
39
134
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
168
688
1.25
2.01
2.2
2.0
ug/l
22.4
162.0
1.36
152
659
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
17
40
2.18
2.01
1.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
651
3727
0.89
2.00
1.4
1.4
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
39
123
1.63
1.99
1.0
1.1
iu/ml
5.0
20.8
1.74
12
46
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
651
3724
0.90
1.98
1.4
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
345
1518
1.17
1.98
1.2
1.2
nmol/l
351.7
360.1
0.31
280
1262
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
54
185
1.50
1.96
6.3
4.2
ug/min
48.7
44.3
0.18
43
145
(3042010) Triglyceride [Moles/volume] in Pleural fluid
63
223
1.45
1.95
1.3
1.3
mmol/l
0.7
1.7
1.35
43
139
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
35
108
1.66
1.94
1.1
1.3
mg/l
38.7
47.7
1.52
12
30
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
717
3315
1.11
1.94
2.1
1.6
nmol/l
0.9
0.8
0.38
598
2809
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
70
254
1.41
1.91
1.3
1.2
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
106
412
1.32
1.91
1.2
1.1
u/ml
3.0
11.4
0.55
48
244
(3011544) Albumin [Mass/volume] in Pleural fluid
45
149
1.55
1.91
1.1
1.1
g/l
18.0
16.8
0.41
39
139
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
226
963
1.21
1.89
6.3
6.6
—
—
—
0
0
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
36
113
1.64
1.89
1.3
1.6
mg/l
2.3
2.9
0.29
24
84
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
36
113
1.64
1.89
1.3
1.6
mg/l
2.3
3.1
0.51
18
82
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
36
113
1.64
1.89
1.3
1.6
mg/l
2.8
2.2
0.25
23
84
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
36
113
1.64
1.89
1.3
1.6
mg/l
2.9
2.0
0.39
23
82
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
36
113
1.64
1.89
1.3
1.6
mg/l
1.6
2.5
0.53
19
72
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
36
113
1.64
1.89
1.3
1.6
mg/l
1.6
2.3
0.44
22
76
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
36
113
1.64
1.89
1.3
1.6
mg/l
4.4
4.2
0.06
20
78
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
36
113
1.64
1.89
1.3
1.6
mg/l
0.7
0.8
0.25
19
80
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
36
113
1.64
1.89
1.3
1.6
mg/l
1.1
1.7
0.42
20
73
(3041672) Baker's yeast Ab [Presence] in Serum
20
52
1.97
1.88
1.0
1.1
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
23
63
1.87
1.87
1.2
1.1
ng/l
3118.3
4176.8
0.30
15
41
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
652
3716
0.90
1.87
1.4
1.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
442
1991
1.14
1.86
1.0
1.1
u/ml
4.4
5.0
0.24
180
797
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
71
261
1.40
1.82
1.2
1.1
pmol/l
3.9
9.5
—
7
37
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
22
60
1.88
1.82
1.2
1.1
pmol/l
180.6
238.2
0.29
16
34
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
22
60
1.88
1.82
1.9
1.5
u/l
0.0
0.4
—
5
18
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
27
79
1.75
1.81
1.1
1.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
28
83
1.73
1.80
1.0
1.2
u/l
54.0
40.9
0.46
23
58
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
109
430
1.30
1.79
1.2
1.1
%
91.5
85.9
0.73
63
190
(3001556) Androgen free Index in Serum or Plasma
38
123
1.59
1.78
1.1
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
155
640
1.24
1.77
1.1
1.1
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
16
39
2.11
1.77
1.0
1.0
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
279
1221
1.17
1.75
1.1
1.2
mg/l
38.3
47.8
2.34
227
1030
(3001964) Herpes simplex virus Ag [Presence] in Specimen
114
454
1.29
1.75
1.7
1.3
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
400
1799
1.14
1.75
1.0
1.1
u/ml
0.2
0.5
1.08
104
391
(3024869) Neuronal Ab [Presence] in Serum
70
259
1.39
1.74
1.1
1.1
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
7
11
3.27
1.73
1.0
1.1
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
15
36
2.14
1.72
1.1
1.1
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
111
442
1.29
1.71
1.1
1.2
%
106.6
104.7
0.16
103
407
(3011335) Digoxin [Mass/volume] in Serum or Plasma
42
141
1.53
1.71
2.1
2.4
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
26
77
1.73
1.69
1.2
1.1
u/ml
1.3
2.4
—
5
8
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
35
113
1.59
1.68
1.2
1.1
u/l
8.1
13.4
1.07
35
113
(40760409) HLA-A [Type] by High resolution
16
40
2.05
1.67
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
16
40
2.05
1.67
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
16
40
2.05
1.67
1.0
1.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
508
2329
1.12
1.66
1.1
1.1
u/ml
2.3
3.2
1.10
227
1202
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
58
210
1.42
1.65
1.0
1.0
ug/l
79.4
81.1
0.13
47
172
(3009677) Dengue virus Ab [Presence] in Serum
20
55
1.87
1.64
1.1
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
12420
62540
1.03
1.62
2.9
2.7
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
32
102
1.61
1.62
1.8
1.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
55
198
1.43
1.62
1.2
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
685
3199
1.10
1.59
1.8
1.6
—
—
—
0
0
(3013862) HLA-DP [Type]
16
41
2.00
1.58
1.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
42
144
1.50
1.57
1.1
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
139
577
1.24
1.56
1.2
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
54
384
0.72
1.55
1.1
1.1
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
38
128
1.52
1.55
1.0
1.2
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
51
365
0.72
1.52
1.1
1.1
mg/g
6.1
7.8
1.43
46
351
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
32
104
1.58
1.52
4.8
3.9
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
29
92
1.62
1.51
1.3
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
120
492
1.25
1.51
1.2
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
109
442
1.27
1.50
1.1
1.1
%
92.5
87.9
0.81
62
195
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
54
198
1.40
1.46
1.2
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
34
114
1.53
1.43
1.1
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
106
432
1.26
1.42
1.0
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
839
3980
1.08
1.41
3.6
3.1
mmol/l
1.6
1.6
0.59
819
3910
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
28
90
1.60
1.40
1.1
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
123
511
1.24
1.40
1.8
2.0
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
48
174
1.42
1.40
1.7
2.6
mmol/l
1.2
1.2
0.00
32
127
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
195
848
1.18
1.39
1.4
1.7
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
150
637
1.21
1.39
1.1
1.1
ng/l
492.4
256.1
0.56
36
163
(3046682) IgA [Presence] in Skin by Immunofluorescence
8
15
2.74
1.39
1.0
1.0
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
86
344
1.28
1.35
1.2
1.2
pmol/l
264.3
315.5
0.63
61
248
(3047352) Trisomy 18 risk [Likelihood] in Fetus
541
3049
0.91
1.34
1.4
1.4
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
25
79
1.62
1.34
1.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
73
286
1.31
1.34
1.1
1.1
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
51
189
1.39
1.33
1.4
1.2
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
85
0.48
1.32
1.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
73
287
1.31
1.31
1.1
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
73
287
1.31
1.31
1.1
1.1
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
14
37
1.94
1.31
1.1
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
361
1652
1.12
1.29
1.8
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
540
3034
0.91
1.27
1.4
1.4
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
49
182
1.38
1.27
1.1
1.1
u/l
16.7
20.2
0.83
33
116
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
288
1673
0.88
1.26
1.1
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
108
449
1.23
1.25
1.5
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
507
2854
0.91
1.25
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
507
2852
0.91
1.24
1.1
1.1
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
11
27
2.09
1.23
1.4
1.1
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
53
201
1.35
1.22
4.4
2.4
umol/l
39.1
41.2
0.29
42
173
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
125
530
1.21
1.21
1.1
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
41
149
1.41
1.21
3.7
1.8
—
—
—
0
0
(3043614) Bacteria identified in Aspirate by Culture
5
9
2.85
1.20
1.0
1.1
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
5
9
2.85
1.20
1.0
1.2
nmol/24h
25.8
28.5
—
5
9
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
192
848
1.16
1.18
1.1
1.1
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
23
74
1.60
1.18
1.3
2.2
nmol/l
2.0
16.1
1.25
23
69
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
42
155
1.39
1.15
2.8
3.4
mg/l
1.3
1.1
0.43
28
108
(43055514) Macroprolactin [Presence] in Serum or Plasma
83
339
1.26
1.15
1.4
1.4
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
35
125
1.44
1.14
1.1
1.2
%
34.2
17.6
—
9
30
(43055442) Apixaban [Mass/volume] in Serum or Plasma
60
235
1.31
1.14
1.5
1.6
ug/l
117.6
110.3
0.22
48
197
(3013945) Hepatitis B virus e Ab [Presence] in Serum
25
83
1.55
1.14
1.8
1.3
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
51
195
1.34
1.14
1.7
1.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
162
709
1.17
1.13
1.8
1.9
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
7
15
2.39
1.13
1.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
16
47
1.75
1.13
1.1
1.0
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
191
848
1.16
1.12
1.1
1.1
u/l
1.1
1.1
0.67
95
410
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
455
2129
1.10
1.11
2.0
1.9
ug/l
21.9
26.5
1.17
446
2081
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
32
113
1.45
1.11
1.0
1.3
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
44
165
1.37
1.11
1.2
1.1
u/ml
0.0
0.6
1.44
25
109
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
252
1143
1.13
1.09
1.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
54
210
1.32
1.09
1.6
1.7
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
24
80
1.54
1.08
1.2
1.6
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
14
40
1.80
1.08
1.1
1.1
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
22
72
1.57
1.07
1.0
1.1
u/ml
59.7
30.4
—
6
10
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
22
72
1.57
1.07
1.0
1.1
u/ml
23.2
24.0
—
5
9
(4027681)
207
928
1.15
1.07
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
195
871
1.15
1.06
1.1
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
964
4658
1.06
1.05
4.6
3.9
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
15
125
0.62
1.03
1.0
1.3
—
—
—
0
0
(3013762) Body weight Measured
20
65
1.58
1.01
1.3
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
54
356
0.78
1.01
6.8
5.8
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
469
2211
1.09
1.00
1.4
1.5
nmol/l
0.3
0.4
0.91
360
1733
(3043238) Trisomy 21 risk [Likelihood] in Fetus
561
3106
0.93
1.00
1.5
1.5
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
43
164
1.35
1.00
1.1
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
97
413
1.21
0.96
1.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
44
170
1.33
0.95
1.1
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
1006
5450
0.95
0.95
1.5
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
719
3935
0.94
0.95
1.5
1.5
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
223
1019
1.12
0.90
1.1
1.1
u/ml
4.9
3.1
0.28
68
291
(3032641) Amino acids panel - Urine
8
21
1.96
0.90
1.6
1.1
—
—
—
0
0
(44806071)
46
181
1.30
0.89
1.1
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
35
132
1.36
0.89
1.2
1.2
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
13
39
1.71
0.88
1.3
1.1
mmol/l
—
—
—
0
0
(3027874) Urate [Moles/volume] in Urine
15
47
1.64
0.88
1.0
1.0
mmol/l
1.9
14.8
—
10
29
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
15
47
1.64
0.88
1.0
1.0
u/ml
0.1
0.2
—
7
22
(3036312) Salmon IgE Ab [Units/volume] in Serum
25
89
1.44
0.87
1.0
1.0
u/ml
0.3
2.0
0.92
14
64
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
79
334
1.21
0.86
1.1
1.2
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
6
15
2.05
0.86
1.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
110
481
1.17
0.84
1.2
1.1
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
39
152
1.32
0.82
1.3
1.2
ug/l
105.4
107.7
0.03
27
96
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
164
742
1.13
0.81
1.1
1.1
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
67
281
1.22
0.80
1.2
1.4
titre
105.5
189.7
0.38
14
32
(3041354) Potassium [Moles/volume] in Venous blood
484
2312
1.08
0.80
2.4
2.4
mmol/l
4.1
4.1
0.64
476
2297
(3035285) Chloride [Moles/volume] in Venous blood
484
2312
1.08
0.80
2.4
2.4
mmol/l
105.6
105.5
0.12
476
2296
(3038515) Glucose [Moles/volume] in Venous blood
784
3806
1.06
0.80
3.8
3.2
mmol/l
7.5
7.7
0.67
767
3745
(3004446) Plasmodium sp identified in Blood by Light microscopy
27
188
0.74
0.79
2.8
2.7
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
46
185
1.28
0.79
1.4
1.3
nmol/l
0.2
0.2
0.05
28
129
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
713
3456
1.06
0.77
1.5
1.4
pmol/l
150.6
152.9
0.03
696
3378
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
36
141
1.31
0.75
2.1
2.5
—
—
—
0
0
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
18
62
1.49
0.75
1.3
1.3
u/field
1.3
1.0
—
8
37
(3009992) Blasts/100 cells in Bone marrow
5
12
2.14
0.75
2.0
1.9
%
16.8
16.9
—
5
12
(3051651) Icteric interference index of Serum or Plasma
235
1093
1.10
0.74
3.0
4.1
—
—
—
0
0
(4133840)
104
459
1.16
0.74
1.2
1.2
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
54
224
1.24
0.73
1.0
1.1
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
20
71
1.45
0.73
11.5
9.6
—
—
—
0
0
(4281824)
329
1828
0.92
0.72
1.2
1.1
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
33
129
1.31
0.71
1.0
1.0
u/ml
0.1
0.2
1.05
20
88
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
73
314
1.19
0.71
1.2
1.1
%
72.3
71.5
0.05
30
83
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
18
63
1.47
0.71
1.1
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
101
447
1.16
0.70
1.7
1.3
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
5
13
1.97
0.70
1.0
1.2
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
5
13
1.97
0.70
1.0
1.2
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
5
13
1.97
0.70
1.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
12
38
1.62
0.70
2.1
1.6
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
276
1542
0.92
0.69
1.3
1.3
pmol/l
161.1
75.0
0.44
98
415
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
32
212
0.77
0.69
1.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
408
1952
1.07
0.69
1.7
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
659
3569
0.95
0.68
1.4
1.3
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
75
325
1.18
0.68
2.9
2.8
ng/l
96.3
103.1
0.11
38
147
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
22
81
1.39
0.68
1.1
1.2
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
14
106
0.68
0.68
1.0
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
40
162
1.27
0.67
1.3
1.7
nmol/l
4.1
7.8
0.82
40
154
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
201
1137
0.91
0.67
1.1
1.1
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
57
241
1.21
0.67
1.7
1.8
pmol/l
34.2
53.5
0.93
48
199
(3025549) Creatine [Moles/time] in 24 hour Urine
32
126
1.30
0.66
1.4
1.4
—
13.6
—
0
7
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
52
218
1.22
0.66
1.2
1.3
%
48.2
52.0
0.17
20
95
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
72
312
1.18
0.66
1.2
1.1
%
76.8
86.5
1.17
31
83
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
24
91
1.35
0.64
1.0
1.1
u/ml
4.5
1.1
0.41
16
72
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
1305
6459
1.04
0.63
1.5
1.5
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
35
141
1.27
0.63
1.3
1.1
umol/24h
1.8
1.8
0.03
35
141
(3025315) Body weight
31
123
1.29
0.62
5.1
3.9
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
30
119
1.29
0.60
1.1
1.1
—
—
—
0
0
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
28
110
1.31
0.60
2.4
2.6
pmol/l
160.0
16.2
—
9
40
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
73
320
1.17
0.60
1.2
1.1
mmol/l
21.3
19.8
2.00
59
292
(3003157) Bacteria [#/volume] in Mother's milk
6
17
1.81
0.60
8.0
6.3
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
6
17
1.81
0.60
1.2
1.0
titre
1473.3
2666.5
—
6
17
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
111
503
1.13
0.59
1.2
1.2
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
27
106
1.31
0.59
1.6
1.3
umol/24h
334.7
291.7
0.57
27
106
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
16
114
0.72
0.58
1.0
1.0
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
6
18
1.71
0.58
1.3
1.4
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
6
18
1.71
0.58
1.3
1.1
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
6
18
1.71
0.58
1.3
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
470
2279
1.06
0.56
2.4
2.4
—
—
—
0
0
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
6
19
1.62
0.55
1.0
1.1
—
—
—
0
0
(4034850)
1166
5780
1.04
0.55
10.8
9.5
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
9
31
1.49
0.55
1.0
1.1
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
9
31
1.49
0.55
1.3
1.8
mu/l
1.7
1.6
—
9
31
(3050794) Legionella sp Ab [Presence] in Serum
36
149
1.24
0.54
1.1
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
35
145
1.24
0.52
1.5
1.8
umol/l
41.6
44.6
0.34
35
145
(3030313) Adrenal Ab [Titer] in Serum
22
146
0.77
0.51
1.1
1.1
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
7
22
1.63
0.51
1.0
1.1
—
—
—
0
0
(40758358) Immune stain study
18
68
1.36
0.51
1.0
1.0
—
—
—
0
0
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
13
46
1.45
0.51
1.1
1.0
u/ml
0.1
0.9
—
6
17
(3041184) Isoniazid [Presence] in Urine
7
23
1.56
0.50
3.0
2.2
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
89
515
0.89
0.49
6.1
6.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
89
515
0.89
0.49
3.1
3.2
—
—
—
0
0
(3006969) Lambda light chains [Mass/volume] in Urine
12
42
1.47
0.49
1.0
1.1
g/l
0.0
0.0
—
5
17
(3044009) aPTT.lupus sensitive (LA screen)
33
137
1.24
0.49
1.2
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
107
492
1.12
0.48
1.1
1.1
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
11
38
1.49
0.48
1.1
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
239
1142
1.07
0.48
1.7
1.9
—
—
—
0
0
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
23
92
1.28
0.46
1.1
1.1
u/field
1.0
1.3
1.47
14
64
(42870560) Thyrotropin [Units/volume] in Cord blood
57
338
0.87
0.46
1.0
1.0
mu/l
11.1
8.4
1.52
51
289
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
36
222
0.83
0.46
1.0
1.0
—
—
—
0
0
(3042951) Complement C1q Ab [Units/volume] in Serum
16
61
1.35
0.44
1.1
1.2
u/ml
24.4
24.0
—
5
12
(3017509) Phencyclidine [Presence] in Urine
38
163
1.20
0.43
2.1
1.7
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
11
39
1.45
0.43
1.0
1.0
—
—
—
0
0
(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum
0
9
0.00
0.43
0.0
1.2
—
—
—
0
0
(3019529) Immunofixation for Cerebral spinal fluid
0
9
0.00
0.43
0.0
1.3
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
21
84
1.28
0.43
1.3
1.0
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
81
370
1.12
0.43
1.4
1.3
g/l
28.6
31.7
0.33
57
287
(3020618) Glucose [Moles/volume] in Synovial fluid
13
48
1.39
0.42
1.1
1.1
mmol/l
5.2
5.1
—
8
36
(3038177) Helicobacter pylori Ab [Presence] in Serum
565
2782
1.04
0.42
1.3
1.2
—
—
—
0
0
(3014178) Parietal cell Ab [Units/volume] in Serum
0
10
0.00
0.42
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
77
353
1.12
0.39
2.4
2.4
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
212
1019
1.07
0.39
1.1
1.1
u/ml
14.9
2.2
0.53
54
255
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
11
40
1.41
0.39
1.0
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
28
118
1.22
0.39
1.0
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
110
515
1.10
0.38
2.0
1.8
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
40
175
1.17
0.38
2.4
2.7
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
29
123
1.21
0.38
1.0
1.2
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
9
35
1.32
0.38
1.8
1.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
38
166
1.17
0.37
1.5
1.2
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
10
36
1.43
0.37
1.1
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
1605
8059
1.02
0.37
3.4
3.5
u/ml
65.0
61.9
0.10
1533
7838
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
21
133
0.81
0.37
1.0
1.0
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
6
21
1.47
0.37
1.0
1.1
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
19
77
1.27
0.36
1.1
1.1
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
23
96
1.23
0.35
1.9
1.3
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
6
22
1.40
0.35
1.2
1.5
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
11
41
1.38
0.35
1.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
47
211
1.14
0.34
2.2
2.6
pmol/l
81.8
73.8
0.16
41
186
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
23
97
1.22
0.33
1.0
1.1
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
46
268
0.88
0.33
1.0
1.0
mmol/l
0.4
-2.4
—
8
61
(3006598) pH of Arterial cord blood
46
268
0.88
0.33
1.0
1.0
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
90
422
1.09
0.33
1.4
1.3
g/l
14.8
13.6
0.66
70
318
(3007919) Fasciola sp Ab [Titer] in Serum
7
27
1.33
0.31
1.0
1.0
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
11
74
0.76
0.31
2.6
2.4
mmol/l
4.6
4.3
0.80
11
66
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
11
42
1.34
0.31
1.1
1.1
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
16
65
1.26
0.31
1.1
1.1
nmol/l
290.8
282.6
0.05
16
65
(3011325) HIV 1+2 Ab [Presence] in Serum
17
70
1.25
0.30
1.1
1.0
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
24
103
1.20
0.30
1.3
1.3
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
67
312
1.10
0.29
1.4
1.6
ug/l
1.8
4.2
0.86
31
190
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
20
85
1.21
0.28
1.2
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
96
531
0.93
0.27
1.0
1.0
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
18
111
0.83
0.26
1.2
1.4
%
31.3
41.1
0.36
11
70
(3004347) Hepatitis D virus Ab [Presence] in Serum
9
38
1.22
0.26
1.0
1.0
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
21
91
1.18
0.25
1.0
1.1
u/ml
4.7
7.0
0.33
16
54
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
51
288
0.91
0.24
1.0
1.1
—
—
—
0
0
(44806420)
105
505
1.07
0.23
2.3
2.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
55
309
0.91
0.23
1.9
2.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
350
1857
0.97
0.23
1.4
1.4
ug/l
3.6
4.0
0.32
307
1618
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
77
366
1.08
0.23
1.1
1.1
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
15
63
1.22
0.23
1.1
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
230
1230
0.96
0.23
1.0
1.0
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
5
20
1.28
0.23
1.0
1.2
—
—
—
0
0
(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.22
0.0
1.0
—
7.3
—
0
6
(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum
0
6
0.00
0.22
0.0
1.2
—
—
—
0
0
(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum
0
6
0.00
0.22
0.0
1.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
23
136
0.87
0.22
1.0
1.2
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
26
152
0.88
0.22
1.0
1.1
—
—
—
0
0
(3015057) Respiratory syncytial virus Ab [Titer] in Serum
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
13
81
0.82
0.22
1.2
1.3
%
1.0
1.4
—
7
50
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
18
78
1.18
0.21
1.1
1.1
mmol/l
8.1
8.8
1.45
18
78
(3039744) RNA polymerase III Ab [Units/volume] in Serum
31
142
1.12
0.20
1.1
1.0
u/ml
3.9
6.4
—
7
13
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
7
29
1.24
0.19
6.4
6.0
mmol/l
0.2
0.3
—
7
29
(3045683) HLA typing for celiac disease panel - Blood or Tissue
201
993
1.04
0.19
1.0
1.0
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
502
2636
0.98
0.19
3.8
3.2
u/ml
31.7
38.0
0.71
483
2540
(3017937) Magnesium [Moles/time] in 24 hour Urine
10
41
1.25
0.18
1.1
1.2
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
21
123
0.88
0.18
1.7
1.5
u/ml
36.7
2.0
0.51
15
107
(3036180) Methadone [Presence] in Urine
7
30
1.20
0.18
3.0
3.5
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
30
138
1.12
0.18
1.7
2.2
%
62.9
59.2
0.22
22
84
(3032868) Hemoglobin electrophoresis panel in Blood
31
143
1.11
0.18
1.5
1.5
—
—
—
0
0
(3003577) Lead [Moles/volume] in Blood
23
133
0.89
0.17
1.3
1.4
umol/l
0.2
0.2
—
7
44
(3016750) Collection duration of Urine
211
1046
1.04
0.17
2.3
2.0
min
500.6
494.6
0.40
147
791
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
84
407
1.06
0.17
1.2
1.1
—
—
—
0
0
(3022670) pH of Venous cord blood
12
73
0.84
0.16
1.1
1.0
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
9
40
1.15
0.16
1.3
1.4
nmol/l
276.7
506.0
—
9
40
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
24
110
1.12
0.15
1.7
2.2
%
7.3
17.6
1.74
15
54
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
9
41
1.13
0.15
1.0
1.0
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
27
125
1.11
0.15
1.0
1.1
u/ml
0.1
0.8
1.64
16
68
(3014891) Appearance of Pleural fluid
58
279
1.07
0.15
1.7
1.6
—
—
—
0
0
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
16
94
0.87
0.15
1.2
1.4
%
9.9
11.8
—
10
64
(3046861) Legionella sp Ag [Presence] in Urine
18
81
1.14
0.15
1.0
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
44
211
1.07
0.13
1.1
1.2
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
18
82
1.13
0.13
6.2
11.0
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
280
1470
0.98
0.13
2.3
2.3
ml
676.1
643.0
0.62
175
1020
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
22
102
1.11
0.12
1.5
1.2
pmol/l
14.5
18.2
0.59
16
94
(3041806) Other cells [#/volume] in Blood by Manual count
93
458
1.04
0.12
1.6
1.3
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
34
162
1.08
0.12
1.0
1.1
u/ml
2.9
5.4
0.41
24
129
(3027231) Wheat IgE Ab [Units/volume] in Serum
56
303
0.95
0.11
1.1
1.1
—
2.8
—
0
10
(3016031) Almond IgE Ab [Units/volume] in Serum
17
97
0.90
0.11
1.0
1.1
u/ml
0.8
1.4
—
9
64
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
19
88
1.11
0.11
1.0
1.0
u/ml
6.8
1.1
0.38
14
64
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
177
885
1.03
0.11
1.5
1.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
36
173
1.07
0.10
1.1
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
820
4252
0.99
0.10
1.5
1.4
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
5
23
1.12
0.10
1.0
1.1
—
—
—
0
0
(43055459) Dabigatran [Mass/volume] in Serum or Plasma
12
54
1.14
0.09
1.4
1.8
ug/l
94.3
118.5
—
7
32
(3020356) Listeria sp identified in Specimen by Organism specific culture
17
96
0.91
0.09
1.0
1.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
124
619
1.03
0.09
2.1
1.7
e6/l
7029.6
3069.6
0.26
82
410
(3017461) Flecainide [Moles/volume] in Serum or Plasma
20
94
1.09
0.09
1.4
1.6
umol/l
0.8
0.7
0.18
14
75
(3018738) Hemoglobin F/Hemoglobin.total in Blood
21
99
1.09
0.09
4.6
2.4
%
12.2
14.4
—
9
28
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
109
543
1.03
0.09
2.0
1.6
e6/l
5043.8
14232.5
1.38
58
277
(3006567) Chloride [Moles/time] in 24 hour Urine
5
31
0.83
0.08
1.0
1.1
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
141
740
0.98
0.07
1.4
1.4
nmol/l
33.2
31.9
0.19
122
685
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
32
155
1.06
0.07
1.1
1.1
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
8
39
1.05
0.07
1.1
1.4
mmol/24h
2.1
2.3
—
8
39
(3049233) Organic acids panel - Urine
9
43
1.07
0.07
1.2
1.2
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
46
226
1.04
0.07
6.1
1.5
mmol/l
6.6
7.4
1.67
15
106
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
23
111
1.06
0.06
1.0
1.1
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
52
258
1.03
0.05
1.3
1.4
u/ml
10.3
7.3
0.13
11
66
(44786800) Granulocytes/100 leukocytes in Body fluid
49
243
1.03
0.05
1.3
1.4
%
26.2
23.0
0.24
35
192
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
14
66
1.09
0.05
1.5
1.1
%
1.4
1.4
0.09
14
66
(3044007) Cell count panel - Peritoneal fluid
100
503
1.02
0.05
2.1
1.7
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
41
203
1.04
0.04
1.5
1.4
%
73.7
74.6
0.07
33
167
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
27
145
0.96
0.04
1.0
1.1
u/ml
0.1
0.6
0.70
15
76
(3024316) Viscosity of Plasma
17
93
0.94
0.04
1.4
1.7
mpas
1.4
1.9
2.73
11
48
(3015076) Soybean IgE Ab [Units/volume] in Serum
178
924
0.99
0.04
1.1
1.1
u/ml
3.7
0.5
0.58
28
121
(3029396) Erythrocyte agglutination [Presence] in Blood
72
363
1.02
0.03
3.2
2.8
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
166
859
0.99
0.02
1.2
1.2
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
28
139
1.03
0.02
1.0
1.1
u/ml
0.0
0.2
1.49
16
69
(3016273) Islet cell 512 Ab [Units/volume] in Serum
23
114
1.04
0.01
1.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
13
63
1.06
0.01
1.2
1.1
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
30
158
0.97
0.01
1.0
1.1
u/ml
17.9
5.6
0.35
22
129
(3000285) Sodium [Moles/volume] in Blood
46
240
0.98
0.01
1.1
1.2
—
—
—
0
0
(3036603) Volume of Urine
223
1149
1.00
0.01
1.9
1.5
ml
1795.9
1934.7
0.55
49
288
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
16
83
0.99
0.00
1.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
45
232
1.00
0.00
1.0
1.1
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
51
261
1.00
0.00
1.1
1.2
u/ml
8.5
6.7
0.08
36
194
(4038314)
23
119
0.99
0.00
1.1
1.2
—
—
—
0
0
(3017830) Gliadin IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042628) Porphyrins [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
5
30
0.86
0.00
2.4
1.1
—
—
—
0
0
(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG
0
5
0.00
0.00
0.0
2.8
—
4.2
—
0
5
(3003220) Varicella zoster virus IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
789.6
—
0
5
(40762887) Creatinine [Moles/volume] in Blood
6
30
1.03
0.00
1.2
1.2
—
—
—
0
0
(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
6
30
1.03
0.00
2.5
2.1
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
6
35
0.88
0.00
1.0
1.1
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
6
33
0.93
0.00
1.3
2.4
mg/l
124.2
164.7
—
6
33
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
5
26
0.99
0.00
1.2
1.1
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: K11_DENTAL_OPER – Dental operations

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).